In April 2002, we privately placed Series A, Series B and Series C preferred shares to several private equity investors. These investors have the right to nominate four directors for election to the Board of Directors, and were granted demand and other registration rights. The interests of the preferred share investors may differ materially from the interests of our common shareholders, and these investors could take actions or make decisions that are not in the best interests of our common shareholders.
The anti-dilution protections afforded to the preferred shareholders could have a material dilutive effect on our common shareholders. Each preferred share, in whole or in part, is convertible at any time at the option of the holder into convertible common shares for that series according to a formula set forth in the description of stock filed as an exhibit to this form 10-K. The convertible common shares are, in turn, convertible into common shares on a one-for-one basis. The number of convertible common shares per preferred shares issuable upon any conversion will be determined by dividing a liquidation preference for the series equal to the aggregate original purchase price of the preferred share plus accrued but unpaid dividends thereon, by the conversion price then in effect. The conversion price is subject to adjustment to avoid dilution in the event of recapitalization, reclassification, stock split, consolidation, merger, amalgamation or other similar event or an issuance of additional common shares in a private placement below the fair market value or in a registered public offering below 95% of fair market value or without consideration. In addition, the conversion price is subject to adjustment for certain loss and loss expense development on reserves for losses incurred on or before September 30, 2001 and for any liability or loss arising out of pending material litigation on December 10, 2001. As of December 31, 2004, the outstanding preferred shares were ultimately convertible into 12.2 million common shares, or 37.4% of our outstanding common shares on a fully converted basis and using the adjusted conversion price of $13.40 in effect as of December 31, 2004. However, because the conversion price for the preferred shares is subject to adjustment for a variety of reasons, including if we have certain types of adverse loss development, the number of our common shares into which the preferred shares are ultimately convertible and, accordingly, the amount of dilution experienced by our common shareholders, could increase.
Furthermore, upon conversion, sales of substantial amounts of common shares by these investors, or the perception that these sales could occur, could adversely affect the market price of the common shares, as well as our ability to raise additional capital in the public equity markets at a desirable time and price.
Item 7 A.
Investments
As of December 31, 2004, our investment portfolio, at fair value, was allocated 62.4% in fixed maturity debt instruments, 25.8% in short-term investments, 11.2% in hedge funds and 0.6% in other invested assets.
At December 31, 2004, 97.3% of the fair value of our fixed maturities and short-term investments portfolio was in obligations rated “A” or better by Moody’s or S&P. Mortgage and asset-backed securities accounted for 26.6% of fixed maturities and short-term investments or 23.5% of our total investment portfolio based on fair value at December 31, 2004. The average yield to maturity of our fixed maturities and short-term investments at December 31, 2004 and 2003 was 3.4% and 3.2%, respectively.
We had no direct investments in real estate or commercial mortgage loans as of December 31, 2004, other than $6.9 million of notes receivable and an equity investment in the JV Agreement described earlier, which are included in Other Assets; however, we may invest in fixed maturities that are secured by commercial mortgages from time to time.
Fixed maturity investments, other than trading securities, are reported at fair value, with the net unrealized gain or loss, net of tax, reported as a separate component of shareholders’ equity. Fixed maturity investments classified as trading securities are reported at fair value, with the net unrealized gain or loss reported as investment income. At December 31, 2004, an after-tax unrealized loss of $3.5 million (loss of 11 cents per share, after considering convertible preferred shares) was included in shareholders’ equity.
Short-term investments are carried at amortized cost, which approximates fair value. Our short-term investments, principally treasury bills and agency securities, amounted to $296.3 million at December 31, 2004, compared to $175.8 million at December 31, 2003.
A significant component of our investment strategy is investing a portion of our invested assets in a diversified portfolio of hedge funds. At December 31, 2004, total hedge fund investments amounted to $129.1 million, representing 11.2% of the total investment portfolio. For the year ended December 31, 2004, our hedge funds yielded a return of 7.8% as compared to 11.8% in 2003. As of December 31, 2004, hedge fund investments with fair values ranging from $0.9 million to $17.2 million were administered by seventeen managers.
Our hedge fund managers invest in a variety of markets utilizing a variety of strategies, generally through the medium of private investment companies or other entities. Criteria for the selection of hedge fund managers include, among other factors, the historical performance and/or recognizable prospects of the particular manager and a substantial personal investment by the manager in the investment program. However, managers without past trading histories or substantial personal investment may also be considered. Generally, our hedge fund managers may be compensated on terms that may include fixed and/or performance-based fees or profit participations.
88
Through our hedge fund managers, we may invest or trade in any securities or instruments including, but not limited to, U.S. and non-U.S. equities and equity-related instruments, currencies, commodities and fixed-income and other debt-related instruments and derivative instruments. Hedge fund managers may use both over-the-counter and exchange traded instruments (including derivative instruments such as swaps, futures and forward agreements), trade on margin and engage in short sales. Substantially all hedge fund managers are expected to employ leverage, to varying degrees, which magnifies both the potential for gain and the exposure to loss, which may be substantial. Leverage may be obtained through margin arrangements, as well as repurchase, reverse repurchase, securities lending and other techniques. Trades may be on or off exchanges and may be in thinly traded securities or instruments, which creates the risk that attempted purchases or sales may adversely affect the price of a particular investment or its liquidation and may increase the difficulty of valuing particular positions.
While we seek capital appreciation with respect to our hedge fund investments, we are also concerned with preservation of capital. Therefore, our hedge fund portfolio is designed to take advantage of broad market opportunities and diversify risk. Nevertheless, our investment policies with respect to our hedge fund investments generally do not restrict us from participating in particular markets, strategies or investments. Further, our hedge fund investments may generally be deployed and redeployed in whatever investment strategies are deemed appropriate under prevailing economic and market conditions in an attempt to achieve capital appreciation, including, if appropriate, a concentration of investments in a relatively small group of strategies or hedge fund managers. Accordingly, the identity and number of hedge fund managers is likely to change over time.
Mariner, as investment advisor, allocates assets to the hedge fund managers. Mariner monitors hedge fund performance and periodically reallocates assets in its discretion. Mariner is familiar with a number of hedge fund investment strategies utilized by our hedge fund managers. Mariner has invested in some of these strategies and has a varying level of knowledge of others. New strategies, or strategies not currently known to Mariner, may come to Mariner’s attention and may be adopted from time to time.
As of December 31, 2004, our investment portfolio also included $6.8 million of other invested assets of which 99% is in two mezzanine bond funds. The remaining aggregate cash call commitments in respect of such investments are $0.3 million.
Hedge funds and other limited partnership investments are accounted for under the equity method. Total investment income for the year ended December 31, 2004, included $10.7 million attributable to hedge funds and other investments.
Our hedge fund and other privately held securities program should be viewed as exposing us to the risk of substantial losses, which we seek to reduce through our multi-asset and multi-management strategy. There can be no assurance, however, that this strategy will prove to be successful.
89
Market Risk
We are exposed to certain market risks, including interest rate and credit risks. The potential for losses exists from changes in interest rates with respect to our investments and borrowings. We are exposed to potential losses from changes in probability of default with respect to our investments. We believe our exposure to foreign exchange risk is not material with respect to our fixed income portfolio.
One of our risk management strategies is to bear market risks that do not correlate with underwriting risks, and limit our exposure to market risks that may prevent us from servicing our insurance obligations. Our Board of Directors approves investment guidelines and the selection of external investment advisers who manage our portfolios. The investment managers make tactical investment decisions within the established guidelines. Management monitors the external advisers through written reports that are reviewed and approved by our Board of Directors or committee thereof. Management also manages diversification strategies across the portfolios in order to limit our potential loss from any single market risk. The performance and risk profiles of the portfolio are reported in various forms throughout the fiscal year to management, our Board of Directors, rating agencies, regulators, and to shareholders.
Our investment portfolio is summarized in Item 1, Business, Item 15, Notes to the Financial Statements and in this Item 7A under the heading “Investments”.
Interest Rate Risk
Our principal fixed maturity market risk exposure is to changes in U.S. interest rates. Changes in interest rates may affect the fair value of our fixed maturity portfolio and subordinated debt. Our holdings subject us to exposures in the treasury, municipal, and various asset-backed sectors. These sectors consist primarily of investment grade securities whose fair value is subject to interest rate, credit, prepayment and extension risk. All fixed maturity investment positions are net long with no “short” or derivative positions.
We believe that reinsurance recoverables and payables do not expose us to significant interest rate risk and are excluded from the analysis below.
In order to measure our exposure to changes in interest rates a sensitivity analysis was performed. Potential loss is measured as a change in fair value, net of applicable taxes. The fair value of the fixed maturity portfolio and subordinated debt at year-end was remeasured from the fair values reported in the financial statements assuming a 100 basis point increase in interest rates using various analytics and models. The potential loss in fair value measured as a proportion of total shareholders’ equity, due to interest rate exposure was estimated at 1.2% at December 31, 2004 and 1.3% at December 31, 2003. There was no significant change in net exposure during the year. Should such interest rate increase occur, only the decline in fair value of our fixed maturity investments would be recorded in our consolidated balance sheet; the decrease in the fair value of the subordinated debt would not be recognized.
90
The estimated potential loss includes declines in the fair value related to prepayment risk associated with the mortgage-related securities. The mortgage sector represents 26.6% of our portfolio of fixed maturities and short-term investments at December 31, 2004. The estimate assumes a similar change in fair value across security sectors with no adjustment for change in value due to credit risk. The interest rate risk related to the short-term investments is not material. The average maturity of these investments is under one year.
Credit Risk
As of December 31, 2004, 88.2% of our investment portfolio, at fair value, consisted of fixed maturities and short-term investments. At December 31, 2004, 97.3% of the fair value of our fixed maturities and short-term investment portfolio was in obligations rated “A” or better by Moody’s or S&P. With respect to diversification, at December 31, 2004 we own 346 individual fixed maturity investments. Non-agency mortgage and asset-backed securities accounted for 14.8% of our investment portfolio based on fair value at December 31, 2004. At December 31, 2004, we had $11.7 million at fair value of privately held fixed maturities that are not traded on a recognized exchange.
Foreign Exchange Risk
Our exposure to foreign exchange risk from our foreign denominated securities is not material. Only a small portion of our investment portfolio is denominated in currencies other than U.S. dollars. Additionally, the carrying value of certain receivables and payables denominated in foreign currencies are carried at fair value. For these reasons, these items have been excluded from the market risk disclosure. We may, however, be exposed to material foreign exchange risks in the event that a significant non-U.S. catastrophe event occurs.
Equity Price Risk
We are not materially exposed to equity price risk other than through our hedge fund investments.
Diversification Benefit
Our risk management strategy includes investments that are expected to reflect offsetting changes in fair value in response to various changes in market risks.
We also hold other investments that are excluded from this disclosure that are expected to provide positive returns under most market conditions representing adverse changes in interest rates and other market factors (See Note 4 of Notes to Consolidated Financial Statements).
91
Item 8. | Financial Statements and Supplementary Data |
The following financial statements are filed as part of this Form 10-K:
| Page |
|
|
PXRE Group Ltd.: | |
| |
Management’s Report on Internal Control Over Financial Reporting | F-1 |
| |
Independent Registered Public Accounting Firm’s Reports | F-2 |
| |
Consolidated Balance Sheets at December 31, 2004 and 2003 | F-5 |
| |
Consolidated Statements of Income and Comprehensive Income for the years ended December 31, 2004, 2003 and 2002 | F-6 |
| |
Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2004, 2003 and 2002 | F-7 |
| |
Consolidated Statements of Cash Flow for the years ended December 31, 2004, 2003 and 2002 | F-8 |
| |
Notes to Consolidated Financial Statements | F-9 |
Item 9. | Changes in and Disagreements With Accountants on Accounting and Financial Disclosure |
Not applicable
Item 9A. | Controls and Procedures |
(a) Evaluation of Disclosure Controls and Procedures
PXRE’s management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were designed and functioning effectively to provide reasonable assurance that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. We believe that a controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.
92
Management’s Report on Internal Control Over Financial Reporting
PXRE’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f). Under the supervision and with the participation of PXRE’s management, including PXRE’s Chief Executive Officer and Chief Financial Officer, PXRE conducted an evaluation of the effectiveness of PXRE’s internal control over financial reporting based on the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on PXRE’s evaluation under the framework in Internal Control – Integrated Framework, PXRE’s management concluded that our internal control over financial reporting was effective as of December 31, 2004. PXRE’s management’s assessment of the effectiveness of PXRE’s internal control over financial reporting as of December 31, 2004 has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which is included herein.
PART III
Item 10. | Directors and Executive Officers of the Registrant |
The information required with respect to our directors and executive officers is incorporated herein by reference to the information contained in the section of our definitive proxy statement for our annual meeting of shareholders to be held April 26, 2005, to be filed with the Securities and Exchange Commission, entitled “Information Concerning Directors and Executive Officers.”
The information with respect to our audit committee financial expert is incorporated herein by reference to the information contained in the section of the proxy statement entitled “Corporate Governance.” We have undertaken to provide to any person, without charge and upon request, a copy of our code of ethics applicable to our chief executive officer and senior financial officers as well as some of our other corporate governance documents. See “Available Information” in the Business section of this Form 10-K.
The information regarding filings under Section 16(a) of the Exchange Act is incorporated herein by reference to the section captioned “Section 16(a) Beneficial Ownership Reporting Compliance” of the Proxy Statement.
Item 11. | Executive Compensation |
The information required by Item 11 of Form 10-K is incorporated by reference to the information contained in the section of the proxy statement entitled “Executive Compensation.”
Item 12. | Security Ownership of Certain Beneficial Owners and Management |
The stock ownership information required by Item 12 of Form 10-K is incorporated by reference to the information contained in the proxy statement in the sections entitled “Outstanding Stock and Voting Rights – Security Ownership of Certain Beneficial Owners” and “Outstanding Stock and Voting Rights – Security Ownership by Management.”
93
The information about our equity compensations plans required by Item 12 of Form 10-K is incorporated by reference to the information contained in the proxy statement in the section entitled “Equity Compensation Plan Information.”
Item 13. | Certain Relationships and Related Transactions |
The information required by Item 13 of Form 10-K is incorporated by reference to the information contained in the proxy statement in the sections entitled “Executive Compensation” and “Certain Business Relationships.”
Item 14. | Principal Accountants’ Fees and Services |
The information required by Item 14 of Form 10-K is incorporated by reference to the information contained in the proxy statement in the section entitled “Principal Accountants’ Fees and Services.”
PART IV
Item 15. | Exhibits, Financial Statement Schedules and Reports on Form 8-K |
(a) The following documents are filed as part of this Form 10-K:
(1) Financial Statements.
| Page |
|
|
PXRE Group Ltd.: | |
| |
Management’s Report on Internal Control Over Financial Reporting | F-1 |
| |
Independent Registered Public Accounting Firm’s Reports | F-2 |
| |
Consolidated Balance Sheets at December 31, 2004 and 2003 | F-5 |
| |
Consolidated Statements of Income and Comprehensive Income for the years ended December 31, 2004, 2003 and 2002 | F-6 |
| |
Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2004, 2003 and 2002 | F-7 |
| |
Consolidated Statements of Cash Flow for the years ended December 31, 2004, 2003 and 2002 | F-8 |
| |
Notes to Consolidated Financial Statements | F-9 |
94
(2) Financial Statements Schedules.
| Page |
|
|
Schedule I – Summary of Investments (The information required by this Schedule is presented in the financial statements and the notes thereto included in this Form 10-K.) | - |
| |
Schedule II – Condensed Financial Information of Registrant | F-38 |
| |
Schedule III – Supplementary Insurance Information | F-39 |
| |
Schedule IV – Reinsurance (The information required by this Schedule is presented in the financial statements and the notes thereto included in this Form 10-K.) | - |
| |
Schedule V – Valuation and Qualifying Accounts and Reserves | F-40 |
| |
Schedule VI – Supplementary Information Concerning Property/Casualty Insurance Operations | F-41 |
| |
Consent of Independent Registered Public Accounting Firm | F-42 |
| |
All other financial statement schedules have been omitted as inapplicable. | |
(3) Exhibits.
A list of exhibits required to be filed as a part of this report is set forth in the Exhibit Index of this Form 10-K, which immediately precedes such exhibits, and is incorporated herein by reference.
(b) Exhibits
See Item 15(a)(3) above.
(d) Financial Statements
See Item 15(a)(2) above.
95
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, PXRE Group Ltd. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| PXRE GROUP LTD. |
| | |
| By: | /s/JEFFREY L. RADKE |
| |
|
| | Jeffrey L. Radke Its President and Chief Executive Officer |
| | |
| Date: | March 1, 2005 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of PXRE Group Ltd. and in the capacity and on the dates indicated:
By: | /s/ JEFFREY L. RADKE | | By: | /s/ JOHN M. MODIN |
|
| | |
|
| Jeffrey L. Radke President and Chief Executive Officer (Principal Executive Officer) | | | John M. Modin Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
| | | | |
Date: | March 1, 2005 | | Date: | March 1, 2005 |
| | | | |
*By: | /s/ GERALD L. RADKE | | *By: | /s/ F. SEDGWICK BROWNE |
|
| | |
|
| Gerald L. Radke Director | | | F. Sedgwick Browne Director |
| | | | |
Date: | February 24, 2005 | | Date: | February 24, 2005 |
| | | | |
*By: | /s/ SUSAN F. CABRERA | | *By: | /s/ BRADLEY E. COOPER |
|
| | |
|
| Susan F. Cabrera Director | | | Bradley E. Cooper Director |
| | | | |
Date: | February 24, 2005 | | Date: | February 24, 2005 |
| | | | |
*By: | /s/ ROBERT W. FIONDELLA | | *By: | /s/ FRANKLIN D. HAFTL |
|
| | |
|
| Robert W. Fiondella Director | | | Franklin D. Haftl Director |
| | | | |
Date: | February 24, 2005 | | Date: | February 24, 2005 |
96
*By: | /s/ CRAIG A. HUFF | | *By: | /s/ MURAL R. JOSEPHSON |
|
| | |
|
| Craig A. Huff Director | | | Mural R. Josephson Director |
| | | | |
Date: | February 24, 2005 | | Date: | February 24, 2005 |
| | | | |
*By: | /s/ WENDY LUSCOMBE | | *By: | /s/ PHILIP R. MCLOUGHLIN |
|
| | |
|
| Wendy Luscombe Director | | | Philip R. McLoughlin Director |
| | | | |
Date: | February 24, 2005 | | Date: | February 24, 2005 |
| | | | |
*By: | /s/ ROBERT M. STAVIS | | | |
|
| | | |
| Robert M. Stavis Director | | | |
| | | | |
Date: | February 24, 2005 | | | |
| | | | |
| | | *By | /s/ JEFFREY L. RADKE |
| | | |
|
| | | | Jeffrey L. Radke Attorney-in-Fact |
97
Management’s Report on Internal Control Over Financial Reporting
To the Board of Directors and Shareholders
PXRE Group Ltd.:
PXRE’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f). Under the supervision and with the participation of PXRE’s management, including PXRE’s Chief Executive Officer and Chief Financial Officer, PXRE conducted an evaluation of the effectiveness of PXRE’s internal control over financial reporting based on the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on PXRE’s evaluation under the framework in Internal Control – Integrated Framework, PXRE’s management concluded that our internal control over financial reporting was effective as of December 31, 2004. PXRE’s management’s assessment of the effectiveness of PXRE’s internal control over financial reporting as of December 31, 2004 has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which is included herein.
/s/ JEFFREY L. RADKE | | /s/ JOHN. M. MODIN |
| |
|
Jeffrey L. Radke | | John M. Modin |
President and Chief Executive Officer | | Executive Vice President and Chief Financial Officer |
| | |
F-1
Report of Independent Registered Public Accounting Firm
The Board of Directors and Shareholders
PXRE Group Ltd.:
We have audited management’s assessment, included in the accompanying Management Report on Internal Control Over Financial Reporting, that PXRE Group Ltd. maintained effective internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). PXRE Group Ltd.’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the Company’s internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
F-2
In our opinion, management’s assessment that PXRE Group Ltd. maintained effective internal control over financial reporting as of December 31, 2004, is fairly stated, in all material respects, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Also, in our opinion, PXRE Group Ltd. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of PXRE Group Ltd., and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of income and comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2004, and our report dated March 1, 2005 expressed an unqualified opinion on those consolidated financial statements.
As discussed in Note 2 to the consolidated financial statements, PXRE Group Ltd. adopted FASB Interpretation No. 46R “Consolidation of Variable Interest Entities,” during 2004.
/s/ KPMG LLP
New York, New York
March 1, 2005
F-3
Report of Independent Registered Public Accounting Firm
The Board of Directors and Shareholders
PXRE Group Ltd.:
We have audited the accompanying consolidated balance sheets of PXRE Group Ltd., and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of income and comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2004. In connection with our audits of the consolidated financial statements, we also have audited financial statement schedules listed in Item 15(a)(2) of this Form 10-K. These consolidated financial statements and financial statement schedules are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedules based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of PXRE Group Ltd. as of December 31, 2004 and 2003, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2004, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the related financial statement schedules, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of PXRE Group Ltd.’s internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated March 1, 2005, expressed an unqualified opinion on management’s assessment of, and the effective operation of, internal control over financial reporting.
As discussed in Note 2 to the consolidated financial statements, PXRE Group Ltd. adopted FASB Interpretation No. 46R “Consolidation of Variable Interest Entities,” during 2004.
/s/ KPMG LLP
New York, New York
March 1, 2005
F-4
PXRE | Consolidated Balance Sheets |
Group Ltd. | (Dollars in thousands, except par value per share) |
| | | December 31, | |
| | |
| |
| | | | 2004 | | | 2003 | |
| | |
|
| |
|
| |
Assets | Investments: | | | | | | | |
| Fixed maturities: | | | | | | | |
| Available-for-sale (amortized cost $705,204 and $613,833, respectively) | | $ | 701,798 | | $ | 617,658 | |
| Trading (cost $13,725 and $20,370, respectively) | | | 15,483 | | | 21,451 | |
| Short-term investments | | | 296,318 | | | 175,771 | |
| Hedge funds (cost $86,549 and $87,691, respectively) | | | 129,118 | | | 121,466 | |
| Other invested assets (cost $5,663 and $9,365, respectively) | | | 6,823 | | | 10,173 | |
| | |
|
| |
|
| |
| Total investments | | | 1,149,540 | | | 946,519 | |
| Cash | | | 15,668 | | | 65,808 | |
| Accrued investment income | | | 8,054 | �� | | 5,490 | |
| Premiums receivable, net | | | 93,116 | | | 79,501 | |
| Other receivables | | | 35,315 | | | 30,695 | |
| Reinsurance recoverable on paid losses | | | 8,003 | | | 15,494 | |
| Reinsurance recoverable on unpaid losses | | | 61,215 | | | 146,924 | |
| Ceded unearned premiums | | | 3,500 | | | 10,454 | |
| Deferred acquisition costs | | | 1,745 | | | 2,495 | |
| Income tax recoverable | | | 31,594 | | | 14,133 | |
| Other assets | | | 46,666 | | | 42,134 | |
| | |
|
| |
|
| |
| Total assets | | $ | 1,454,416 | | $ | 1,359,647 | |
| | |
|
| |
|
| |
Liabilities | Reserve for losses and loss expenses | | $ | 460,084 | | $ | 450,635 | |
| Reserve for unearned premiums | | | 15,952 | | | 21,566 | |
| Subordinated debt | | | 167,075 | | | — | |
| Reinsurance balances payable | | | 10,937 | | | 53,373 | |
| Deposit liabilities | | | 72,143 | | | 80,583 | |
| Other liabilities | | | 31,670 | | | 32,133 | |
| | |
|
| |
|
| |
| Total liabilities | | | 757,861 | | | 638,290 | |
| | |
|
| |
|
| |
| Minority interest in consolidated subsidiary: | | | | | | | |
| Company-obligated mandatorily redeemable capital trust pass-through securities of subsidiary trust holding solely a company-guaranteed related subordinated debt | | | — | | | 156,841 | |
| | |
|
| |
|
| |
Shareholders’ Equity | Serial convertible preferred shares, $1.00 par value, $10,000 stated value -- 10 million shares authorized, 0.02 million shares issued and outstanding | | | 163,871 | | | 172,190 | |
| Common shares, $1.00 par value -- 50 million shares authorized, 20.5 million and 13.3 million shares issued and outstanding, respectively | | | 20,469 | | | 13,277 | |
| Additional paid-in capital | | | 329,730 | | | 192,078 | |
| | | | | | | | |
| Accumulated other comprehensive income net of deferred income tax (benefit) expense of $(900) and $1,242, respectively | | | (4,855 | ) | | 1,692 | |
| Retained earnings | | | 194,081 | | | 188,670 | |
| Restricted shares at cost (0.4 million and 0.3 million shares, respectively) | | | (6,741 | ) | | (3,391 | ) |
| | |
|
| |
|
| |
| Total shareholders’ equity | | | 696,555 | | | 564,516 | |
| | |
|
| |
|
| |
| Total liabilities and shareholders’ equity | | $ | 1,454,416 | | $ | 1,359,647 | |
| | |
|
| |
|
| |
| | | | | | | | |
| The accompanying notes are an integral part of these statements. | | | | | | | |
F-5
PXRE | Consolidated Statements of Income and Comprehensive Income |
Group Ltd. | (Dollars in thousands, except per share amounts) |
| | | Year Ended December 31, | |
| | |
| |
| | | | 2004 | | | 2003 | | | 2002 | |
| | |
|
| |
|
| |
|
| |
Revenues | Net premiums earned | | $ | 308,072 | | $ | 320,933 | | $ | 269,360 | |
| Net investment income | | | 26,178 | | | 26,931 | | | 24,893 | |
| Net realized investment (losses) gains | | | (150 | ) | | 2,447 | | | 8,981 | |
| Fee income | | | 1,785 | | | 5,014 | | | 3,432 | |
| | |
|
| |
|
| |
|
| |
| | | | 335,885 | | | 355,325 | | | 306,666 | |
| | |
|
| |
|
| |
|
| |
Losses and | Losses and loss expenses incurred | | | 226,347 | | | 157,598 | | | 125,361 | |
Expenses | Commissions and brokerage | | | 36,111 | | | 47,360 | | | 53,391 | |
| Operating expenses | | | 41,293 | | | 39,701 | | | 34,228 | |
| Foreign exchange losses (gains) | | | 80 | | | 143 | | | (273 | ) |
| Interest expense | | | 14,389 | | | 2,506 | | | 2,939 | |
| Minority interest in consolidated subsidiaries | | | — | | | 10,528 | | | 8,646 | |
| | |
|
| |
|
| |
|
| |
| | | | 318,220 | | | 257,836 | | | 224,292 | |
| | |
|
| |
|
| |
|
| |
| | | | | | | | | | | |
| Income before income taxes, cumulative effect of accounting change and convertible preferred share dividends | | | 17,665 | | | 97,489 | | | 82,374 | |
| Income tax (benefit) provision | | | (6,234 | ) | | 841 | | | 17,829 | |
| | |
|
| |
|
| |
|
| |
| Income before cumulative effect of accounting change and convertible preferred share dividends | | | 23,899 | | | 96,648 | | | 64,545 | |
| Cumulative effect of accounting change, net of $0.2 million tax benefit | | | (1,053 | ) | | — | | | — | |
| | |
|
| |
|
| |
|
| |
| Net income before convertible preferred share dividends | | $ | 22,846 | | $ | 96,648 | | $ | 64,545 | |
| | |
|
| |
|
| |
|
| |
| Convertible preferred share dividends | | | 14,018 | | | 13,113 | | | 9,077 | |
| | |
|
| |
|
| |
|
| |
| Net income available to common shareholders | | $ | 8,828 | | $ | 83,535 | | $ | 55,468 | |
| | |
|
| |
|
| |
|
| |
Comprehensive | Net income before convertible preferred share dividends | | $ | 22,846 | | $ | 96,648 | | $ | 64,545 | |
Income, Net of | Net unrealized (depreciation) appreciation on investments | | | (5,218 | ) | | (6,396 | ) | | 7,664 | |
Tax | Minimum additional pension liability | | | (1,329 | ) | | — | | | — | |
| Net unrealized appreciation (depreciation) on cash flow hedge | | | — | | | 946 | | | (223 | ) |
| | |
|
| |
|
| |
|
| |
| Comprehensive income | | $ | 16,299 | | $ | 91,198 | | $ | 71,986 | |
| | |
|
| |
|
| |
|
| |
Per Share | Basic: | | | | | | | | | | |
| Net income before cumulative effect of accounting change and convertible preferred share dividends | | $ | 1.65 | | $ | 8.06 | | $ | 5.47 | |
| Cumulative effect of accounting change | | | (0.07 | ) | | — | | | — | |
| Convertible preferred share dividends | | | (0.97 | ) | | (1.09 | ) | | (0.77 | ) |
| | |
|
| |
|
| |
|
| |
| Net income available to common shareholders | | $ | 0.61 | | $ | 6.97 | | $ | 4.70 | |
| | |
|
| |
|
| |
|
| |
| Average shares outstanding (000’s) | | | 14,433 | | | 11,992 | | | 11,802 | |
| | |
|
| |
|
| |
|
| |
| Diluted: | | | | | | | | | | |
| Net income before cumulative effect of accounting change | | $ | 0.86 | | $ | 4.10 | | $ | 3.28 | |
| Cumulative effect of accounting change | | | (0.04 | ) | | — | | | — | |
| | |
|
| |
|
| |
|
| |
| Net income | | $ | 0.82 | | $ | 4.10 | | $ | 3.28 | |
| | |
|
| |
|
| |
|
| |
| Average shares outstanding (000’s) | | | 27,745 | | | 23,575 | | | 19,662 | |
| | |
|
| |
|
| |
|
| |
| | | | | | | | | | | |
| The accompanying notes are an integral part of these statements. | | | | | | | | |
F-6
PXRE | Consolidated Statements of Shareholders’ Equity |
Group Ltd. | (Dollars in thousands) |
| | Years Ended December 31, 2004, 2003 and 2002 | |
| |
| |
| | Convertible Preferred Shares | | Common Shares | | Additional Paid-in Capital | | Accumulated Other Comprehensive Income | | Retained Earnings | | Restricted Shares | | Total Shareholders’ Equity | |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Balance at December 31, 2001 | | $ | — | | $ | 11,873 | | $ | 175,405 | | $ | (299 | ) | $ | 55,473 | | $ | (2,672 | ) | $ | 239,780 | |
Net income before convertible preferred shares dividends | | | | | | | | | | | | | | | 64,545 | | | | | | 64,545 | |
Unrealized appreciation on investments, net | | | | | | | | | | | | 7,664 | | | | | | | | | 7,664 | |
Unrealized depreciation on cash flow hedge, net | | | | | | | | | | | | (223 | ) | | | | | | | | (223 | ) |
Issuance of convertible preferred shares | | | 150,000 | | | | | | (9,112 | ) | | | | | | | | | | | 140,888 | |
Issuance of common shares | | | | | | 157 | | | 3,000 | | | | | | | | | | | | 3,157 | |
Repurchase/cancellation of common shares | | | | | | | | | (671 | ) | | | | | | | | | | | (671 | ) |
Issuance of restricted shares | | | | | | | | | | | | | | | | | | (886 | ) | | (886 | ) |
Amortization of restricted shares | | | | | | | | | | | | | | | | | | 1,845 | | | 1,845 | |
Dividends to convertible preferred shareholders | | | 9,077 | | | | | | | | | | | | (9,077 | ) | | | | | — | |
Dividends paid to common shareholders | | | | | | | | | | | | | | | (2,879 | ) | | | | | (2,879 | ) |
Tax effect of stock options exercised | | | | | | | | | 316 | | | | | | | | | | | | 316 | |
Other | | | | | | | | | (72 | ) | | | | | | | | | | | (72 | ) |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Balance at December 31, 2002 | | | 159,077 | | | 12,030 | | | 168,866 | | | 7,142 | | | 108,062 | | | (1,713 | ) | | 453,464 | |
Net income before convertible preferred shares dividends | | | | | | | | | | | | | | | 96,648 | | | | | | 96,648 | |
Unrealized depreciation on investments, net | | | | | | | | | | | | (6,396 | ) | | | | | | | | (6,396 | ) |
Unrealized appreciation on cash flow hedge, net | | | | | | | | | | | | 946 | | | | | | | | | 946 | |
Issuance of common shares | | | | | | 1,247 | | | 25,084 | | | | | | | | | | | | 26,331 | |
Repurchase/cancellation of common shares | | | | | | | | | (2,058 | ) | | | | | | | | | | | (2,058 | ) |
Issuance of restricted shares | | | | | | | | | | | | | | | | | | (4,582 | ) | | (4,582 | ) |
Amortization of restricted shares | | | | | | | | | | | | | | | | | | 2,904 | | | 2,904 | |
Dividends to convertible preferred shareholders | | | 13,113 | | | | | | | | | | | | (13,113 | ) | | | | | — | |
Dividends paid to common shareholders | | | | | | | | | | | | | | | (2,927 | ) | | | | | (2,927 | ) |
Tax effect of stock options exercised | | | | | | | | | 186 | | | | | | | | | | | | 186 | |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Balance at December 31, 2003 | | | 172,190 | | | 13,277 | | | 192,078 | | | 1,692 | | | 188,670 | | | (3,391 | ) | | 564,516 | |
Net income before convertible preferred shares dividends | | | | | | | | | | | | | | | 22,846 | | | | | | 22,846 | |
Unrealized depreciation on investments, net | | | | | | | | | | | | (5,218 | ) | | | | | | | | (5,218 | ) |
Minimum additional pension liability, net | | | | | | | | | | | | (1,329 | ) | | | | | | | | (1,329 | ) |
Conversion of convertible preferred shares | | | (22,337 | ) | | | | | | | | | | | | | | | | | (22,337 | ) |
Issuance of common shares | | | | | | 7,192 | | | 137,331 | | | | | | | | | | | | 144,523 | |
Repurchase/cancellation of common shares | | | | | | | | | (1,254 | ) | | | | | | | | | | | (1,254 | ) |
Issuance of restricted shares | | | | | | | | | | | | | | | | | | (7,291 | ) | | (7,291 | ) |
Amortization of restricted shares | | | | | | | | | | | | | | | | | | 3,941 | | | 3,941 | |
Dividends to convertible preferred shareholders | | | 14,018 | | | | | | | | | | | | (14,018 | ) | | | | | — | |
Dividends paid to common shareholders | | | | | | | | | | | | | | | (3,417 | ) | | | | | (3,417 | ) |
Tax effect of stock options exercised | | | | | | | | | 1,575 | | | | | | | | | | | | 1,575 | |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Balance at December 31, 2004 | | $ | 163,871 | | $ | 20,469 | | $ | 329,730 | | $ | (4,855 | ) | $ | 194,081 | | $ | (6,741 | ) | $ | 696,555 | |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
The accompanying notes are an integral part of these statements.
F-7
PXRE | |
Group Ltd. | Consolidated Statements of Cash Flows |
| | | Year Ended December 31, | |
| | |
| |
| | | 2004 | | 2003 | | 2002 | |
| | |
|
| |
|
| |
|
| |
Cash Flows | Premiums collected, net of reinsurance | | $ | 253,361 | | $ | 248,857 | | $ | 313,673 | |
from Operating | Loss and loss adjustment expenses paid, net of reinsurance | | | (123,698 | ) | | (80,113 | ) | | (106,220 | ) |
Activities | Commission and brokerage paid, net of fee income | | | (34,543 | ) | | (21,738 | ) | | (61,673 | ) |
| Operating expenses paid | | | (38,189 | ) | | (34,346 | ) | | (27,834 | ) |
| Net investment income received | | | 15,894 | | | 13,719 | | | 11,917 | |
| Interest paid | | | (15,138 | ) | | (11,229 | ) | | (11,136 | ) |
| Income taxes (paid) recovered | | | (6,271 | ) | | (15,680 | ) | | 7,123 | |
| Trading portfolio purchased | | | — | | | (21,607 | ) | | (30,886 | ) |
| Trading portfolio disposed | | | 6,965 | | | 25,183 | | | 38,123 | |
| Deposit (paid) received | | | (8,440 | ) | | 45,434 | | | 21,818 | |
| Other | | | (4,590 | ) | | 5,777 | | | (15,523 | ) |
| | |
|
| |
|
| |
|
| |
| Net cash provided by operating activities | | | 45,351 | | | 154,257 | | | 139,382 | |
| | |
|
| |
|
| |
|
| |
Cash Flows | Fixed maturities available for sale purchased | | | (496,986 | ) | | (527,249 | ) | | (430,722 | ) |
from Investing | Fixed maturities available for sale disposed or matured | | | 405,393 | | | 378,996 | | | 189,969 | |
Activities | Hedge funds purchased | | | (13,123 | ) | | (35,000 | ) | | (30,366 | ) |
| Hedge funds disposed | | | 15,149 | | | 40,009 | | | 14,265 | |
| Other invested assets purchased | | | — | | | (314 | ) | | (283 | ) |
| Other invested assets disposed | | | 4,417 | | | 1,673 | | | 10,558 | |
| Net change in short-term investments | | | (120,547 | ) | | (42,453 | ) | | 20,185 | |
| Payable for securities | | | (18 | ) | | (4 | ) | | (82 | ) |
| | |
|
| |
|
| |
|
| |
| Net cash used by investing activities | | | (205,715 | ) | | (184,342 | ) | | (226,476 | ) |
| | |
|
| |
|
| |
|
| |
Cash Flows | Proceeds from issuance of common shares | | | 114,701 | | | 21,538 | | | 2,128 | |
from Financing | Proceeds from issuance of convertible preferred shares | | | — | | | — | | | 140,888 | |
Activities | Cash dividends paid to common shareholders | | | (3,417 | ) | | (2,927 | ) | | (2,879 | ) |
| Proceeds from issuance of minority interest in consolidated subsidiaries | | | — | | | 62,500 | | | — | |
| Repayment of debt | | | — | | | (30,000 | ) | | (25,000 | ) |
| Repurchase of minority interest in consolidated subsidiary | | | — | | | — | | | (3,773 | ) |
| Cost of shares repurchased | | | (1,060 | ) | | (1,848 | ) | | (528 | ) |
| | |
|
| |
|
| |
|
| |
| Net cash provided by financing activities | | | 110,224 | | | 49,263 | | | 110,836 | |
| | |
|
| |
|
| |
|
| |
| Net change in cash | | | (50,140 | ) | | 19,178 | | | 23,742 | |
| Cash, beginning of year | | | 65,808 | | | 46,630 | | | 22,888 | |
| | |
|
| |
|
| |
|
| |
| Cash, end of year | | $ | 15,668 | | $ | 65,808 | | $ | 46,630 | |
| | |
|
| |
|
| |
|
| |
| Reconciliation of net income to net cash provided by operating activities: | | | | | | | | | | |
| Net income before convertible preferred share dividends | | $ | 22,846 | | $ | 96,648 | | $ | 64,545 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | | | | |
| Reserve for losses and loss expenses | | | 9,449 | | | 2,807 | | | (5,876 | ) |
| Reserve for unearned premiums | | | 1,340 | | | (42,148 | ) | | 25,088 | |
| Deferred acquisition costs | | | 750 | | | 20,226 | | | (15,409 | ) |
| Receivables | | | (18,234 | ) | | (5,855 | ) | | 3,143 | |
| Reinsurance balances payable | | | (42,436 | ) | | (27,717 | ) | | 2,913 | |
| Reinsurance recoverable | | | 93,201 | | | 74,678 | | | 25,018 | |
| Income taxes | | | (12,787 | ) | | (14,808 | ) | | 25,017 | |
| Equity in earnings of limited partnerships | | | (10,744 | ) | | (13,373 | ) | | (9,323 | ) |
| Trading portfolio purchased | | | — | | | (21,607 | ) | | (30,886 | ) |
| Trading portfolio disposed | | | 6,965 | | | 25,183 | | | 38,123 | |
| Deposit liability | | | (8,440 | ) | | 45,434 | | | 21,818 | |
| Other | | | 3,441 | | | 14,789 | | | (4,789 | ) |
| | |
|
| |
|
| |
|
| |
| Net cash provided by operating activities | | $ | 45,351 | | $ | 154,257 | | $ | 139,382 | |
| | |
|
| |
|
| |
|
| |
| | | | | | | | | | | |
| The accompanying notes are an integral part of these statements. | | | | | | | | |
F-8
PXRE | Notes to Consolidated Financial Statements |
Group Ltd. | Years Ended December 31, 2004, 2003 and 2002 |
1. Organization
PXRE Group Ltd. (the “Company” or collectively with its subsidiaries, “PXRE”) is an insurance holding company organized in Bermuda. The Company provides reinsurance products and services to a worldwide marketplace through its wholly owned subsidiary operations located in Bermuda, Barbados, Europe and the United States. PXRE’s primary focus is providing property catastrophe reinsurance and retrocessional coverage. PXRE also provides marine, aviation and aerospace products and services.
2. Significant Accounting Policies
Basis of Presentation and Consolidation
The consolidated financial statements have been prepared in U.S. dollars in conformity with accounting principles generally accepted (“GAAP”) in the United States of America. These statements reflect the consolidated operations of the Company and its wholly owned subsidiaries, including PXRE Corporation (“PXRE Delaware”), PXRE Reinsurance Company (“PXRE Reinsurance”), PXRE Reinsurance Ltd. (“PXRE Bermuda”), PXRE Reinsurance (Barbados) Ltd. (“PXRE Barbados”), PXRE Solutions, Inc. (“PXRE Solutions”), PXRE Solutions S.A. (“PXRE Europe”), and PXRE Limited. All material intercompany transactions have been eliminated in preparing these consolidated financial statements.
GAAP requires management to make estimates and assumptions that affect the (i) reported amount of assets and liabilities; (ii) disclosure of contingent assets and liabilities at the date of the financial statements; and (iii) the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Certain reclassifications have been made for 2002 and 2003 to conform to the 2004 presentation.
Premiums Assumed and Ceded
Premiums on assumed and ceded reinsurance business are recorded as earned evenly over the contract period based on estimated subject premiums. Adjustments based on actual subject premiums are recorded once ascertained. The portion of assumed and ceded premiums written relating to unexpired coverages at the end of the period is recorded as unearned premiums and ceded unearned premiums, respectively.
Assumed and ceded reinstatement premiums on reinsurance business are estimated and recorded as earned following a loss event based on contract terms and estimated losses incurred.
Assumed reinsurance and retrocessional contracts that do not both transfer significant insurance risk and result in the reasonable possibility that PXRE or its retrocessionaires may realize a significant loss from the insurance risk assumed are accounted for as deposits with interest income or expense credited or charged to the contract deposits and included in net investment income or fee income. These contract deposits are included in other assets and deposit liabilities in the Consolidated Balance Sheets. Premiums on assumed and ceded retroactive reinsurance contracts are earned when written.
F-9
Deferred Acquisition Costs
Acquisition costs consist of commission and brokerage expenses incurred in connection with contract issuance, net of acquisition costs ceded and fee income. These costs are deferred and amortized over the period in which the related premiums are earned. Deferred acquisition costs are reviewed to determine that they do not exceed recoverable amounts, after considering investment income.
Fee Income
Fee income is recorded as earned evenly over the contract period under various arrangements whereby PXRE acts as underwriting manager for other insurers and reinsurers. These fees are initially based on premium volume, but are adjusted in some cases through contingent profit commissions related to underwriting results. In addition, fees are earned from certain finite contracts accounted for as deposits.
Reserve for Losses and Loss Expenses
A reserve for losses and loss expenses is established equal to an amount estimated to settle incurred losses. This liability is based on individual case estimates provided for reported losses for known events and estimates of incurred but not reported losses. The reserve for losses and loss expense is necessarily based on estimates and the ultimate liability may vary from such estimates. Any adjustments to these estimates are reflected in income when known. Reinsurance recoverables on paid and unpaid losses are reported as assets. Reinsurance recoverable on paid losses represents amounts recoverable from retrocessionaires at the end of the period for assumed losses previously paid. Reinsurance recoverables are recognized in a manner consistent with the underlying loss and loss expense reserve. Provisions are established for all reinsurance recoveries that are considered doubtful.
Liabilities on assumed retroactive reinsurance contracts are established for the estimated loss PXRE ultimately expects to pay out. If such losses are greater than the related assumed earned premium, a deferred charge is recorded and included in other assets in the Consolidated Balance Sheets. Reinsurance recoverables on ceded retroactive reinsurance contracts are recorded for the estimated recovery that PXRE ultimately expects to receive. If such recoverables are greater than the related ceded earned premium, a deferred gain is recorded and included in other liabilities in the Consolidated Balance Sheets. The deferred charge or gain is amortized over the estimated remaining settlement periods using the interest method. When changes in the amount or the timing of payments on retroactive balances occur, a cumulative amortization adjustment is recognized in earnings in the period of the change.
F-10
Investments
Fixed maturity investments are considered available-for-sale or trading and are reported at fair value. Unrealized gains and losses associated with the available-for-sale portfolio, as a result of temporary changes in fair value during the period such investments are held, are reflected net of income taxes in shareholders’ equity. Unrealized losses associated with the available-for-sale portfolio that are deemed other than temporary are charged to operations. Unrealized gains and losses associated with the trading portfolio are recognized in investment income.
Short-term investments, which have an original maturity of one year or less, are carried at amortized cost, which approximates fair value.
Investments in limited partnership hedge funds and other limited partnerships are reported under the equity method, which includes the cost of the investment and subsequent proportional share of the partnership earnings. Under the equity method, earnings are recorded in investment income.
Realized gains or losses on disposition of investments are determined on the basis of specific identification. The amortization of premiums and accretion of discounts for fixed maturity investments are computed utilizing the interest method. The effective yield under the interest method is adjusted for anticipated prepayments and extensions.
Fair Value of Financial Instruments
Fair values of certain assets and liabilities are based on published market values, if available, or estimates based upon fair values of similar issues. Fair values are reported in Notes 4 and 5.
Debt Issuance Costs
Debt issuance costs associated with the issuance of $103.1 million 8.85% PXRE Capital Trust Pass-through Securities (trust preferred securities), the $18.0 million 7.35% PXRE Capital Statutory Trust II trust preferred securities, the $15.5 million 9.75% PXRE Capital Trust III trust preferred securities, the $20.6 million 7.70% PXRE Capital Statutory Trust V trust preferred securities, and the $10.3 million 7.58% PXRE Capital Trust VI trust preferred securities are being amortized over the term of the related outstanding debt using the interest method.
Foreign Exchange
Foreign currency assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Resulting gains and losses are reflected in income for the period.
Federal Income Taxes
Deferred tax assets and liabilities reflect the expected future tax consequences of temporary differences between carrying amounts and the tax bases of PXRE’s assets and liabilities.
F-11
Comprehensive Income
Comprehensive income is comprised of net income before convertible preferred share dividends and other comprehensive income. Other comprehensive income consists of the after-tax change in the net unrealized appreciation or depreciation of investments, the change in fair value of derivative instruments that qualify for hedge accounting, and a portion of the change in pension liabilities.
Earnings Per Share
Basic earnings per share is determined by dividing net earnings by the weighted average number of common shares outstanding. On a diluted basis, both net earnings and shares outstanding are adjusted to reflect the potential dilution that could occur if securities convertible into common shares or other contracts to issue common shares were exercised or converted into common shares or resulted in the issuance of common shares that then shared in the earnings of the entity, unless the effect of the assumed conversion is anti-dilutive.
Share-Based Compensation
At December 31, 2004, PXRE has share option plans, which are accounted for under the recognition and measurement principles of the Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees”, and related Interpretations. No share-based compensation cost is reflected in net income, as all options granted under those plans had an exercise price equal to the market value of the underlying common shares on the date of grant. The following table illustrates the effect on net income and earnings per share if PXRE had applied the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Statement of Financial Accounting Standards (“SFAS”) No. 123, “Accounting for Stock-Based Compensation” to share-based employee compensation.
($000’s, except per share data) | | 2004 | | 2003 | | 2002 | |
| |
|
| |
|
| |
|
| |
Net income before convertible preferred share dividends: | | | | | | | | | | |
As reported | | $ | 22,846 | | $ | 96,648 | | $ | 64,545 | |
| |
|
| |
|
| |
|
| |
Deduct: | | | | | | | | | | |
Total share-based compensation expense determined under fair value based method for all awards, net of related tax effects | | | (2,180 | ) | | (2,927 | ) | | (2,464 | ) |
| |
|
| |
|
| |
|
| |
Pro-forma | | $ | 20,666 | | $ | 93,721 | | $ | 62,081 | |
| |
|
| |
|
| |
|
| |
Basic income per share: | | | | | | | | | | |
As reported | | $ | 0.61 | | $ | 6.97 | | $ | 4.70 | |
Pro-forma | | $ | 0.46 | | $ | 6.72 | | $ | 4.49 | |
Diluted income per share: | | | | | | | | | | |
As reported | | $ | 0.82 | | $ | 4.10 | | $ | 3.28 | |
Pro-forma | | $ | 0.74 | | $ | 3.98 | | $ | 3.16 | |
| | | | | | | | | | |
F-12
Debt and Equity Classification
In May 2003, the FASB issued SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” This statement establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. It requires that an issuer classify a financial instrument that is within the scope of the statement as a liability or an asset in some circumstances. PXRE adopted this statement during the quarter ended September 30, 2003, however, due to certain parts of this statement being deferred by the FASB, the adoption of this statement did not have any impact on PXRE’s Consolidated Financial Statements, financial position or results of operations until the quarter ended March 31, 2004. Accordingly, as of March 31, 2004, PXRE’s capital trust pass-through securities were reclassified on its Consolidated Balance Sheet to liabilities and entitled “Subordinated debt.” In PXRE’s Consolidated Statements of Income and Comprehensive Income for the year ended 2004, the interest expense related to these securities was included with “Interest expense,” whereas for the years ended 2003 and 2002 it was included with “Minority interest in consolidated subsidiaries” as SFAS 150 did not permit these changes to be made retroactively.
Consolidation of Variable Interest Entities
In January 2003, the FASB issued FASB Interpretation No. 46, “Consolidation of Variable Interest Entities” (“FIN 46”), which requires consolidation of all “Variable Interest Entities” (“VIEs”) by the “primary beneficiary,” as these terms are defined in FIN 46, and on October 9, 2003 the FASB issued FASB Staff Position FIN 46-6, “Effective Date of FASB Interpretation No. 46, Consolidation of VIEs”, which required PXRE to implement FIN 46 during the quarter ended March 31, 2004. The adoption of this statement resulted in PXRE deconsolidating the five special purpose trusts which issued PXRE’s trust preferred securities. As a result, the subordinated loans from the trusts are reflected as liabilities under the caption “Subordinated debt” on PXRE’s December 31, 2004 Consolidated Balance Sheet, while PXRE’s investments of approximately $5.2 million in such trusts in the form of equity, which prior to March 31, 2004 were eliminated on consolidation, are reflected as assets under the caption “Other assets” with a corresponding increase in liabilities under the caption “Subordinated debt.” FIN 46 did not permit these changes to be made retroactively. In addition, gains on the repurchase of $5.2 million of PXRE’s trust preferred securities in prior periods of $1.1 million, net of tax, that were previously accounted for as extinguishments of debt, were reversed during the quarter ended March 31, 2004 and presented as a cumulative effect of an accounting change in PXRE’s Consolidated Statement of Income and Comprehensive Income during 2004. These repurchased securities are reflected in PXRE’s December 31, 2004 Consolidated Balance Sheet under the caption “Fixed Maturities: Available-for-sale.”
Consolidated Statement of Changes in Cash Flow
In the first quarter of 2004, the Company changed the presentation of its Consolidated Statement of Changes in Cash Flow to the direct cash flow method, replacing the indirect cash flow method as previously presented. Amounts presented for the years ended December 31, 2003 and 2002 were reclassified to be consistent with the new presentation.
F-13
Share-Based Payment
In December, 2004, the FASB issued SFAS No. 123 R, “Share-Based Payment.” This statement requires companies to recognize in the income statement, the grant date fair value of stock options and other-equity based compensation issued to employees. It is effective for the interim period commencing after June 15, 2005. The adoption of SFAS 123 R is expected to reduce net income in 2005 by less than $1.2 million.
3. Underwriting
Premiums written and earned for the years ended December 31, 2004, 2003 and 2002 are as follows:
($000’s) | | | 2004 | | | 2003 | | | 2002 | |
| |
|
| |
|
| |
|
| |
Premiums written | | | | | | | | | | |
Gross premiums written | | $ | 346,035 | | $ | 339,140 | | $ | 366,768 | |
Ceded premiums written | | | (36,248 | ) | | (60,729 | ) | | (72,285 | ) |
| |
|
| |
|
| |
|
| |
Net premiums written | | $ | 309,787 | | $ | 278,411 | | $ | 294,483 | |
| |
|
| |
|
| |
|
| |
Premiums earned | | | | | | | | | | |
Gross premiums earned | | $ | 351,274 | | $ | 381,705 | | $ | 349,312 | |
Ceded premiums earned | | | (43,202 | ) | | (60,772 | ) | | (79,952 | ) |
| |
|
| |
|
| |
|
| |
Net premiums earned | | $ | 308,072 | | $ | 320,933 | | $ | 269,360 | |
| |
|
| |
|
| |
|
| |
Premiums written were assumed principally through reinsurance brokers or intermediaries. In 2004, 2003 and 2002, four, four and five reinsurance intermediaries, respectively, individually accounted for more than 10% of gross premiums written, and collectively accounted for approximately 78%, 78% and 84% of gross premiums written, respectively.
Included in ceded premiums written are $7.1 million, $26.1 million and $30.5 million of premiums ceded in 2004, 2003 and 2002, respectively to one reinsurer, Select Reinsurance Ltd. (“Select Re”). Fees earned from Select Re were $0.8 million, $3.8 million and $3.0 million in 2004, 2003, and 2002, respectively. Net assets due from Select Re at December 31, 2004, are $31.1 million, all of which are secured by assets in trust accounts for which PXRE is the beneficiary. The President and a major shareholder of Mariner Investment Group (“Mariner”), one of PXRE’s investment managers, is also a member of the Board of Select Re and one of Select Re’s founding shareholders.
PXRE from time to time purchases catastrophe retrocessional coverage for its own protection, depending on market conditions. PXRE purchases reinsurance primarily to reduce its exposure to severe losses related to any one event or catastrophe. PXRE currently has reinsurance treaties in place with several different coverages, territories, limits and retentions that serve to reduce a large gross loss emanating from any one event. In addition, primarily related to exposure assumed on per-risk treaties, PXRE purchases clash reinsurance protection which allows us to recover losses ceded by more than one reinsured related to any one particular property. In the event that retrocessionaires are unable to meet their contractual obligations, PXRE would remain liable for the underlying covered claims.
F-14
At December 31, 2004, PXRE had balances with an insurer, Legion Insurance Company (“Legion”), which has been in liquidation, amounting to $9.0 million of premiums receivable net of contingent commission. PXRE also had losses and loss expense liabilities due to Legion of $14.1 million at December 31, 2004. PXRE’s reinsurance contracts with Legion contain offset clauses whose enforceability is subject to Pennsylvania law.
PXRE has both ceded and assumed reinsurance contracts that involve the withholding of premiums by the cedent or PXRE, as the case may be. PXRE held premiums and accrued investment income due to reinsurers at December 31, 2004 and 2003 of $86.4 million and $124.1 million, respectively. These amounts are included, net of related receivables, under the caption, “Reinsurance balances payable” in the Company’s Consolidated Balance Sheets. PXRE owes fixed rates of interest to the retrocessionaires for these funds withheld arrangements, and on a weighted average basis such rates during the years ended December 31, 2004, 2003 and 2002 were 7.4%, 6.8% and 7.8%, respectively. Under these arrangements, PXRE reduced investment income during the years ended December 31, 2004, 2003 and 2002 by $8.0 million, $9.1 million and $9.8 million, respectively. Additionally, PXRE was owed premiums and accrued investment income due from reinsureds at December 31, 2004 and 2003 of $0.0 million and $26.4 million, respectively. These amounts are included, net of related payables, under the caption “Other Receivables” in the Company’s Consolidated Balance Sheets. PXRE is entitled to fixed rates of interest from the cedents for these funds withheld arrangements, and on a weighted average basis such rate during the years ended December 31, 2004, 2003 and 2002 was 4.0%, 7.0% and 7.0%, respectively. Under these arrangements, PXRE recognized investment income during the years ended December 31, 2004, 2003 and 2002 of $0.9 million, $1.7 million and $1.7 million, respectively.
Activity in the reserve for losses and loss expenses for the years ended December 31, 2004, 2003 and 2002 is as follows:
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
|
| |
|
| |
|
| |
Net balance at January 1 | | $ | 303,711 | | $ | 240,385 | | $ | 207,798 | |
Incurred related to: | | | | | | | | | | |
Current year | | | 214,316 | | | 112,917 | | | 101,456 | |
Prior years | | | 12,031 | | | 44,681 | | | 23,905 | |
| |
|
| |
|
| |
|
| |
Total incurred | | | 226,347 | | | 157,598 | | | 125,361 | |
| |
|
| |
|
| |
|
| |
Paid related to: | | | | | | | | | | |
Current year | | | (12,628 | ) | | (26,058 | ) | | (18,618 | ) |
Prior years | | | (119,493 | ) | | (66,957 | ) | | (81,259 | ) |
| |
|
| |
|
| |
|
| |
Total paid | | | (132,121 | ) | | (93,015 | ) | | (99,877 | ) |
| |
|
| |
|
| |
|
| |
Retroactive reinsurance assumed | | | (1,037 | ) | | (5,571 | ) | | 2,976 | |
Foreign exchange adjustments | | | 1,969 | | | 4,314 | | | 4,127 | |
| |
|
| |
|
| |
|
| |
Net balance at December 31 | | | 398,869 | | | 303,711 | | | 240,385 | |
Reinsurance recoverable on unpaid losses | | | 61,215 | | | 146,924 | | | 207,444 | |
| |
|
| |
|
| |
|
| |
Gross balance at December 31 | | $ | 460,084 | | $ | 450,635 | | $ | 447,829 | |
| |
|
| |
|
| |
|
| |
F-15
During 2004, PXRE experienced net adverse development of $12.0 million for prior-year losses and loss expenses, comprised of $11.4 million cat and risk excess net favorable development and $23.4 million exited lines net adverse development. The favorable development in the cat and risk excess business was primarily related to case reserve takedowns from past significant catastrophes, such as the 2002 European floods. The $23.4 million net adverse development related to exited lines is due primarily to $13.7 million of adverse loss development on a finite contract with Lumbermens Mutual Casualty Company (“LMC”). During the fourth quarter of 2004, this contract was commuted. The Company also experienced $19.7 million of adverse development on direct casualty reinsurance operations. The primary cause of the adverse development was higher than expected reported losses in 2004. Favorable development in other exited lines offset the adverse development experienced on the contract with LMC and direct casualty reinsurance operations. During the third and fourth quarters of 2004, The Company completed commutations of two exited direct general liability reinsurance programs, the first resulting in a $2.0 million reduction in incurred losses and the second in a $1.0 million increase in incurred losses.
During 2003, PXRE incurred net adverse development of $44.7 million for prior-year loss and loss expenses, $21.8 million of which was due to loss development on exited direct casualty reinsurance operations, $8.8 million adverse development from aerospace claims arising to a significant degree from the first receipt of notice that the increase in industry losses related to a 1998 air crash had resulted in the exhaustion of deductibles under three aerospace contracts between PXRE and Reliance Insurance Company and $8.2 million of development from finite contracts, $7.3 million of which related to the contract with LMC mentioned above.
During 2002, PXRE incurred net adverse development for prior-year losses amounting to $23.9 million, $16.9 million of which was due to loss development in the exited lines segment relating primarily to the 2000 and 2001 underwriting years. Adverse development of $16.7 million was primarily caused by larger than expected reported claims under direct reinsurance contracts, corroborated by revised industry data.
F-16
4. Investments
The book value, gross unrealized gains, gross unrealized losses and estimated fair value of investments in fixed maturities as of December 31, 2004 and 2003 are shown below:
($000’s) | | Book Value | | Gross Unrealized Gains | | Gross Unrealized Losses | | Estimated Fair Value | |
| |
|
| |
|
| |
|
| |
|
| |
2004 | | | | | | | | | | | | | |
Available for sale: | | | | | | | | | | | | | |
United States government securities | | $ | 62,212 | | $ | 120 | | $ | 323 | | $ | 62,009 | |
United States government sponsored agency debentures | | | 122,297 | | | 451 | | | 794 | | | 121,954 | |
United States government sponsored agency mortgage-backed securities | | | 99,653 | | | 419 | | | 161 | | | 99,911 | |
Other mortgage and asset-backed securities | | | 172,927 | | | 588 | | | 3,502 | | | 170,013 | |
Obligations of states and political subdivisions | | | 2,056 | | | 6 | | | 8 | | | 2,054 | |
Corporate securities | | | 246,059 | | | 2,685 | | | 2,887 | | | 245,857 | |
| |
|
| |
|
| |
|
| |
|
| |
| | | 705,204 | | | 4,269 | | | 7,675 | | | 701,798 | |
| |
|
| |
|
| |
|
| |
|
| |
Trading: | | | | | | | | | | | | | |
Foreign denominated securities | | | 15,483 | | | — | | | — | | | 15,483 | |
| |
|
| |
|
| |
|
| |
|
| |
Total fixed maturities | | $ | 720,687 | | $ | 4,269 | | $ | 7,675 | | $ | 717,281 | |
| |
|
| |
|
| |
|
| |
|
| |
($000’s) | | Book Value | | Gross Unrealized Gains | | Gross Unrealized Losses | | Estimated Fair Value | |
| |
|
| |
|
| |
|
| |
|
| |
2003 | | | | | | | | | | | | | |
Available for sale: | | | | | | | | | | | | | |
United States government securities | | $ | 40,219 | | $ | 79 | | $ | 61 | | $ | 40,237 | |
United States government sponsored agency debentures | | | 115,375 | | | 1,504 | | | 1,439 | | | 115,440 | |
United States government sponsored agency mortgage-backed securities | | | 133,723 | | | 822 | | | 222 | | | 134,323 | |
Other mortgage and asset-backed securities | | | 145,772 | | | 1,409 | | | 985 | | | 146,196 | |
Obligations of states and political subdivisions | | | 18,005 | | | 579 | | | — | | | 18,584 | |
Corporate securities | | | 160,739 | | | 3,640 | | | 1,501 | | | 162,878 | |
| |
|
| |
|
| |
|
| |
|
| |
| | | 613,833 | | | 8,033 | | | 4,208 | | | 617,658 | |
| |
|
| |
|
| |
|
| |
|
| |
Trading: | | | | | | | | | | | | | |
Foreign denominated securities | | | 21,451 | | | — | | | — | | | 21,451 | |
| |
|
| |
|
| |
|
| |
|
| |
Total fixed maturities | | $ | 635,284 | | $ | 8,033 | | $ | 4,208 | | $ | 639,109 | |
| |
|
| |
|
| |
|
| |
|
| |
F-17
PXRE regularly monitors the difference between the estimated fair values of investments and their cost or book values to identify underperforming investments and whether declines in value are temporary in nature, or “other than temporary.” If a decline in the value of a particular investment is deemed to be temporary, the decline is recorded as an unrealized loss, net of tax, in shareholders’ equity. If the decline is “other than temporary,” the carrying value of the investment is written down and a realized loss is recorded on the statement of income. The Company formally reviews each quarter the unrealized losses by value, and all investments that have been in an unrealized loss position for more than six months. In assessing whether an investment is suffering a decline in value that is other than temporary, particular attention is paid to those trading at 80% or less of original cost, and those investments that have been downgraded by any of the major ratings agencies, general market conditions, and the status of principal and interest payments. If a decline is deemed to be other than temporary, a realized investment loss is recognized for the impairment.
The following table summarizes investments with unrealized losses at fair value by length of continuous unrealized loss position as of December 31, 2004:
| | One Year or Less | | Over One Year | |
| |
| |
| |
($000’s) | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | |
| |
|
| |
|
| |
|
| |
|
| |
United States government securities | | $ | 49,213 | | $ | (323 | ) | $ | — | | $ | — | |
United States government sponsored agency debentures | | | 90,815 | | | (794 | ) | | — | | | — | |
United States government sponsored agency mortgage- backed securities | | | 13,025 | | | (11 | ) | | 6,519 | | | (150 | ) |
Other mortgage and asset-backed securities | | | 112,257 | | | (2,999 | ) | | 12,253 | | | (504 | ) |
Obligations of states and political subdivisions | | | 1,242 | | | (8 | ) | | — | | | — | |
Corporate securities | | | 149,412 | | | (2,220 | ) | | 26,014 | | | (666 | ) |
| |
|
| |
|
| |
|
| |
|
| |
Total temporarily impaired securities | | $ | 415,964 | | $ | (6,355 | ) | $ | 44,786 | | $ | (1,320 | ) |
| |
|
| |
|
| |
|
| |
|
| |
The following table summarizes investments with unrealized losses at fair value by length of continuous unrealized loss position as of December 31, 2003:
| | One Year or Less | | Over One Year | |
| |
| |
| |
($000’s) | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | |
| |
|
| |
|
| |
|
| |
|
| |
United States treasury securities | | $ | 30,614 | | $ | (61 | ) | $ | — | | $ | — | |
United States government sponsored agency debentures | | | 34,384 | | | (1,439 | ) | | — | | | — | |
United States government sponsored agency mortgage- backed securities | | | 52,337 | | | (222 | ) | | — | | | — | |
Other mortgage and asset-backed securities | | | 71,545 | | | (985 | ) | | — | | | — | |
Corporate securities | | | 54,656 | | | (1,501 | ) | | — | | | — | |
| |
|
| |
|
| |
|
| |
|
| |
Total temporarily impaired securities | | $ | 243,536 | | $ | (4,208 | ) | $ | — | | $ | — | |
| |
|
| |
|
| |
|
| |
|
| |
Included in other comprehensive income in 2004 is $5.2 million of net unrealized depreciation on investments which includes $5.1 million of unrealized net losses arising during the year less $0.1 million of reclassification adjustments for net gains included in net income.
F-18
Proceeds, gross realized investment gains, and gross realized investment losses from sales of fixed maturity investments before maturity or securities that prepay and from sales of equity securities were as follows:
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
|
| |
|
| |
|
| |
Proceeds from sales | | | | | | | | | | |
Fixed maturities | | $ | 341,911 | | $ | 348,884 | | $ | 206,537 | |
| |
|
| |
|
| |
|
| |
Equity securities | | $ | 21 | | $ | 328 | | $ | 275 | |
| |
|
| |
|
| |
|
| |
Gross realized gains | | | | | | | | | | |
Fixed maturities | | $ | 2,954 | | $ | 6,546 | | $ | 10,566 | |
Equity securities | | | 21 | | | — | | | — | |
| |
|
| |
|
| |
|
| |
| | | 2,975 | | | 6,546 | | | 10,566 | |
| |
|
| |
|
| |
|
| |
Gross realized losses | | | | | | | | | | |
Fixed maturities | | | (2,834 | ) | | (3,956 | ) | | (1,352 | ) |
Equity securities | | | — | | | — | | | (123 | ) |
Other | | | (291 | ) | | (143 | ) | | (110 | ) |
| |
|
| |
|
| |
|
| |
| | | (3,125 | ) | | (4,099 | ) | | (1,585 | ) |
| |
|
| |
|
| |
|
| |
Net realized investment (losses) gains | | $ | (150 | ) | $ | 2,447 | | $ | 8,981 | |
| |
|
| |
|
| |
|
| |
Included in gross realized losses are the other than temporary write downs of asset backed securities in 2004, 2003 and 2002 of $0.1 million, $0.2 million, and $0.7 million, respectively.
The components of net investment income were as follows:
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
|
| |
|
| |
|
| |
Fixed maturity investments | | $ | 25,986 | | $ | 23,325 | | $ | 22,397 | |
Hedge funds and other limited partnerships | | | 10,744 | | | 13,373 | | | 9,343 | |
Cash, short-term and other | | | 4,527 | | | 3,313 | | | 4,653 | |
| |
|
| |
|
| |
|
| |
| | | 41,257 | | | 40,011 | | | 36,393 | |
Less investment expenses | | | (2,800 | ) | | (2,316 | ) | | (1,954 | ) |
Less interest expense on funds held and deposit liabilities | | | (12,279 | ) | | (10,764 | ) | | (9,546 | ) |
| |
|
| |
|
| |
|
| |
Net investment income | | $ | 26,178 | | $ | 26,931 | | $ | 24,893 | |
| |
|
| |
|
| |
|
| |
Investment expenses principally represent fees paid to General Re-New England Asset Management, Inc., Mariner, financing costs, and bank charges.
F-19
Investment Maturity Distributions
The book value and estimated fair value of fixed maturity investments at December 31, 2004 by expected maturity date are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
($000’s) | | Book Value | | Estimated Fair Value | |
| |
|
| |
|
| |
Fixed Maturity: | | | | | | | |
One year or less | | $ | 79,054 | | $ | 78,856 | |
Over 1 through 5 years | | | 563,793 | | | 560,838 | |
Over 5 through 10 years | | | 65,419 | | | 65,386 | |
Over 10 through 20 years | | | 3,800 | | | 5,200 | |
Over 20 years | | | 8,621 | | | 7,001 | |
| |
|
| |
|
| |
Total fixed maturities | | $ | 720,687 | | $ | 717,281 | |
| |
|
| |
|
| |
In addition to fixed maturities, PXRE held $296.3 million and $175.8 million of short-term investments at December 31, 2004 and 2003, respectively, comprised principally of treasury bills and agency securities.
PXRE also held $129.1 million and $121.5 million of limited partnership hedge fund assets, including funds managed by Mariner, at December 31, 2004 and 2003, respectively, that are accounted for under the equity method, as follows:
| | 2004 | | 2003 | |
| |
| |
| |
($000’s) | | $ | | Ownership % | | $ | | Ownership % | |
| |
| |
| |
| |
| |
Mariner Partners, L.P. | | $ | 17,235 | | 3.5 | | $ | 16,557 | | 3.6 | |
Mariner Select, L.P. | | | 14,783 | | 2.5 | | | 14,186 | | 6.7 | |
Caspian Capital Partners, L.P. (a Mariner fund) | | | 9,501 | | 2.2 | | | 9,663 | | 2.6 | |
Mariner Opportunities, L.P. | | | 8,863 | | 8.1 | | | 9,708 | | 11.6 | |
Other | | | 78,736 | | 1.5 to 9.6 | | | 71,352 | | 2.7 to 18.0 | |
| |
|
| | | |
|
| | | |
Total hedge funds | | $ | 129,118 | | | | $ | 121,466 | | | |
| |
|
| | | |
|
| | | |
Restricted Assets
Under the terms of certain reinsurance agreements, irrevocable letters of credit in the amount of $8.1 million were issued at December 31, 2004, in respect of reported loss reserves and unearned premiums. Cash and investments amounting to $23.2 million have been pledged as collateral with issuing banks. In addition, cash and securities amounting to $9.8 million at December 31, 2004 were on deposit with various state insurance departments and overseas banks in order to comply with insurance laws.
F-20
PXRE, in connection with the capitalization of PXRE’s Lloyd’s Syndicate 1224, has placed on deposit $22.5 million par value of securities as collateral for Lloyd’s of London (“Lloyd’s”). In addition, cash and invested assets held by PXRE’s Lloyd’s Syndicate 1224, amounting to $11.9 million at December 31, 2004 are restricted from being paid as a dividend until the run-off of the exited Lloyd’s business has been completed.
PXRE has outstanding commitments for funding investments in a limited partnership of $0.3 million at December 31, 2004.
PXRE has deposited securities with a fair value of $64.5 million at December 31, 2004 in a trust for the benefit of a cedent in connection with certain finite reinsurance transactions.
5. Subordinated Debt
Trust preferred securities were classified as minority interest in consolidated subsidiaries prior to 2004. Trust preferred securities are mandatorily redeemable subordinated debt securities issued to separate special purpose trusts holding solely those securities. As discussed in Note 2, following the implementation of SFAS 150 and FIN 46 during the quarter ended March 31, 2004, these trusts are no longer consolidated and the securities issued to these trusts by PXRE (rather than the securities issued by the trusts as was done previously) are now classified as liabilities on PXRE’s December 31, 2004 Consolidated Balance Sheet. The subordinated debt securities are as follows:
($000’s) | | December 31, 2004 | | December 31, 2003 | |
| |
| |
| |
8.85% fixed rate due February 1, 2027 | | $ | 102,640 | | $ | 94,341 | |
7.35% fixed/floating rate due May 15, 2033 | | | 18,042 | | | 17,500 | |
9.75% fixed rate due May 23, 2033 | | | 15,464 | | | 15,000 | |
7.70% fixed/floating rate due October 29, 2033 | | | 20,619 | | | 20,000 | |
7.58% fixed/floating rate due September 30, 2033 | | | 10,310 | | | 10,000 | |
| |
|
| |
|
| |
| | $ | 167,075 | | $ | 156,841 | |
| |
|
| |
|
| |
The 8.85% fixed rate capital trust pass-through securities pay interest semi-annually and are redeemable by PXRE from February 1, 2007 at 104.180% declining to 100.418% at February 1, 2016, and at par thereafter.
The 7.35% fixed/floating rate capital trust pass-through securities initially pay interest quarterly at a fixed rate of 7.35% for 5 years and then at a floating rate of 3 month LIBOR plus 4.1% reset quarterly thereafter, and are redeemable by PXRE at par on or after May 15, 2008.
The 9.75% fixed rate capital trust pass-through securities pay interest quarterly and are redeemable by PXRE from May 23, 2008 at 104.875% declining to 100.975% at May 23, 2013, and at par thereafter.
The 7.70% fixed/floating rate capital trust pass-through securities initially pay interest quarterly at a rate of 7.70% for 5 years and then at a floating rate of 3 month LIBOR plus 3.85% reset quarterly thereafter, and are redeemable by PXRE at par on or after October 29, 2008.
The 7.58% fixed/floating rate capital trust pass-through securities initially pay interest quarterly at a rate of 7.58% for 5 years and then at a floating rate of 3 month LIBOR plus 3.90% reset quarterly thereafter, and are redeemable by PXRE at par on or after September 30, 2008.
F-21
PXRE has the option to defer interest payments on the capital trust pass-through securities and redeem them earlier than the due dates, subject to limits and penalties as set out in the relevant indentures.
On December 30, 1998, PXRE Delaware entered into a Credit Agreement with Wachovia Bank, National Association (formerly known as First Union National Bank), (“Wachovia”), to arrange and syndicate for it a revolving credit facility of up to $75.0 million. Commitments under this credit facility terminated on May 16, 2003 following a repayment of $20.0 million on March 31, 2003 and the final payment of $10.0 million on May 16, 2003. PXRE Delaware entered into a cash flow hedge interest rate swap agreement with Wachovia that had the intended effect of converting floating rate borrowings by PXRE Delaware to a fixed rate borrowing at an annual rate of 7.34%. The fair value of the interest rate swap agreement at December 31, 2003 was approximately $0.9 million, and on November 30, 2004 PXRE terminated the agreement by paying $0.3 million. Following the repayments under PXRE’s credit facility with Wachovia in 2003 this interest rate swap, previously accounted for as a cash flow hedge, was no longer effective. Consequently $1.1 million has been charged as interest expense in 2003. This charge did not impact shareholders’ equity because it was previously recorded as a component of other comprehensive income.
6. Taxation
PXRE is incorporated under the laws of Bermuda and, under current Bermuda law, is not obligated to pay any taxes in Bermuda based upon income or capital gains. PXRE has received an undertaking from the Supervisor of Insurance in Bermuda pursuant to the provisions of the Exempted Undertakings Tax Protection Act, 1966, which exempts PXRE from any Bermuda taxes computed on profits, income or any capital asset, gain or appreciation, or any tax in the nature of estate duty or inheritance tax, at least until the year 2016.
PXRE does not consider itself to be engaged in a trade or business in the United States and, accordingly, does not expect to be subject to direct United States income taxation.
The United States subsidiaries of PXRE file a consolidated U.S. federal income tax return.
Income (loss) before income taxes and cumulative effect of accounting change for the years ended December 31, 2004, 2003 and 2002 was as follows under the following jurisdictions:
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
U.S. | | $ | (21,147 | ) | $ | 1,868 | | $ | 50,619 | |
Bermuda and subsidiary | | | 34,384 | | | 90,104 | | | 31,553 | |
Barbados | | | 4,428 | | | 5,517 | | | 202 | |
| |
|
| |
|
| |
|
| |
Total | | $ | 17,665 | | $ | 97,489 | | $ | 82,374 | |
| |
|
| |
|
| |
|
| |
F-22
The components of the (benefit) provision for income taxes for the years ended December 31, 2004, 2003 and 2002 are as follows:
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
Current | | | | | | | | | | |
U.S. | | $ | (15,242 | ) | $ | 12,125 | | $ | (867 | ) |
Foreign | | | 4,180 | | | 566 | | | 389 | |
| |
|
| |
|
| |
|
| |
Subtotal | | | (11,062 | ) | | 12,691 | | | (478 | ) |
Deferred U.S. | | | 4,828 | | | (11,850 | ) | | 18,307 | |
| |
|
| |
|
| |
|
| |
Income tax (benefit) provision before change in accounting | | | (6,234 | ) | | 841 | | | 17,829 | |
Income tax benefit from change in accounting | | | (240 | ) | | — | | | — | |
| |
|
| |
|
| |
|
| |
Income tax (benefit) provision | | $ | (6,474 | ) | $ | 841 | | $ | 17,829 | |
| |
|
| |
|
| |
|
| |
The significant components of the net deferred income tax asset (liability) are as follows:
($000’s) | | 2004 | | 2003 | |
| |
| |
| |
Deferred income tax asset: | | | | | | | |
Discounted reserves and unearned premiums | | $ | 10,101 | | $ | 11,421 | |
Retroactive reinsurance contracts | | | — | | | 2,842 | |
Deferred compensation and benefits | | | 1,149 | | | 2,585 | |
Allowance for doubtful accounts | | | 995 | | | 805 | |
Excess tax over book basis in invested assets | | | 900 | | | 54 | |
Additional minimum pension liability | | | 716 | | | — | |
Cash flow hedge | | | — | | | 122 | |
Other, net | | | 871 | | | 535 | |
| |
|
| |
|
| |
Total deferred income tax asset | | $ | 14,732 | | $ | 18,364 | |
| |
|
| |
|
| |
Deferred income tax liability: | | | | | | | |
Excess book over tax basis in limited partnerships | | $ | (2,187 | ) | $ | (1,905 | ) |
Market discount | | | (138 | ) | | (1,406 | ) |
Investments and unrealized foreign exchange | | | (704 | ) | | (1,125 | ) |
Deferred acquisition costs | | | (61 | ) | | (313 | ) |
Other, net | | | (177 | ) | | (419 | ) |
| |
|
| |
|
| |
Total deferred income tax liability | | $ | (3,267 | ) | $ | (5,168 | ) |
| |
|
| |
|
| |
Net deferred income tax asset | | $ | 11,465 | | $ | 13,196 | |
| |
|
| |
|
| |
Management has reviewed PXRE’s deferred tax asset, and has concluded that it is realizable and no valuation allowance is necessary.
Income tax recoverable consists of the following:
($000’s) | | 2004 | | 2003 | |
| |
| |
| |
Current tax asset | | $ | 20,129 | | $ | 937 | |
Deferred tax asset | | | 11,465 | | | 13,196 | |
| |
|
| |
|
| |
Income tax recoverable | | $ | 31,594 | | $ | 14,133 | |
| |
|
| |
|
| |
F-23
The (benefit) provision for income taxes differs from the amount of income tax determined by applying the applicable U.S. statutory Federal income tax rate of 35% to pretax income from operations as a result of the following differences:
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
Statutory U.S. rate | | $ | 6,183 | | $ | 34,122 | | $ | 28,831 | |
Tax exempt interest | | | (100 | ) | | (678 | ) | | (619 | ) |
Bermuda and subsidiary income | | | (12,034 | ) | | (31,537 | ) | | (11,044 | ) |
Foreign income – Barbados | | | (1,550 | ) | | (1,931 | ) | | (71 | ) |
Barbados tax | | | 4,112 | | | 516 | | | 389 | |
Reserve for prior year taxes | | | (2,600 | ) | | — | | | — | |
Other, net | | | (245 | ) | | 349 | | | 343 | |
| |
|
| |
|
| |
|
| |
Income tax (benefit) provision | | $ | (6,234 | ) | $ | 841 | | $ | 17,829 | |
| |
|
| |
|
| |
|
| |
7. Shareholders’ Equity
On November 23, 2004, PXRE completed a public offering of 5.2 million of its common shares at $23.75 per share, pursuant to a Shelf Registration on Form S-3, filed in 2003 for up to $150.0 million of securities, consisting of 3.7 million shares offered by the Company and 1.5 million shares offered by certain selling shareholders. The underwriters were given an option to purchase up to an additional 0.8 million common shares, 0.7 million from the Company and 0.1 million from the selling shareholders, solely to cover overallotments, if any, which option they exercised December 2, 2004.
The Company did not receive any of the proceeds from the sale of shares by the selling shareholders. The selling shareholders converted 2,208 preferred shares, including accrued dividends to 1.6 million common shares sold in the public offering, including the overallotment. Net proceeds to the Company from the sale of common shares sold by the Company were approximately $98.2 million, including the overallotment. PXRE used the net proceeds for general corporate purposes, including contributions to the capital of PXRE Bermuda to support growth in its business.
On December 16, 2003, PXRE completed a public offering of 2.2 million of its common shares at $21.75 per share, pursuant to a Shelf Registration on Form S-3, filed in 2003 for up to $150.0 million of securities. Of the 2.2 million shares sold, 1.1 million were offered by PXRE and 1.1 million were offered by Phoenix Life Insurance Company (“Phoenix”), one of the Company’s common shareholders. The underwriters were given an option to purchase up to an additional 0.3 million common shares from the Company, solely to cover overallotments, if any, which option they exercised January 22, 2004.
The Company did not receive any of the proceeds from the sale of shares by Phoenix. Net proceeds to the Company from the sale of the common shares sold by the Company were approximately $20.4 million and $6.3 million for the overallotment. PXRE used the net proceeds from the sale of common shares for general corporate purposes, including contributions to the capital of PXRE Bermuda to support growth in its business.
F-24
Absent a specific waiver by PXRE’s Board of Directors, the Company’s Bye-Laws restrict the ownership and voting rights of any shareholder who directly or indirectly would own more than 9.9% of the outstanding common shares of the Company. The restriction requires the prompt disposition of any shares held in violation of the provision and limits the voting power of a shareholder with more than 9.9% of the outstanding shares to the voting power of a shareholder with 9.9% of the outstanding common shares.
On April 4, 2002, the Company raised $150.0 million of additional capital by issuing 15,000 convertible voting preferred shares in a private placement not involving a public offering under Section 4(2) of the Securities Act of 1933, as amended. The convertible preferred share investment occurred pursuant to a share purchase agreement, dated as of December 10, 2001, between the Company and certain investors. On February 12, 2002, the shareholders approved the sale and issuance of three series of convertible preferred shares pursuant to the share purchase agreement, including 7,500 Series A convertible preferred shares, 5,000 Series B convertible preferred shares, and 2,500 Series C convertible preferred shares. Proceeds of the offering of the convertible preferred shares, net of offering expenses of $9.1 million, amounted to $140.9 million.
The convertible preferred shares accrue cumulative dividends per share at the rate per annum of 8% of the sum of the stated value of each share plus any accrued and unpaid dividend thereon payable on a quarterly basis. The shareholders also voted to approve the division of 20.0 million of PXRE’s 50.0 million authorized common shares into three new classes of convertible common shares including 10.0 million Class A convertible voting common shares, 6.7 million Class B convertible voting common shares, and 3.3 million Class C convertible voting common shares. No convertible voting common shares of any class are currently outstanding.
As of December 31, 2004, 16,387 convertible preferred shares were outstanding, which were convertible into 12.2 million common shares. Convertible preferred shares are convertible into convertible common shares at the option of the holder at any time at a conversion price equal to the original conversion price, subject to adjustment if PXRE experiences adverse development in excess of a $7.0 million after-tax threshold. The number of convertible common shares issued upon the conversion of each convertible preferred share would be equal to the sum of the original purchase price ($10,000) of such convertible preferred share plus accrued but unpaid dividends divided by the adjusted conversion price. Certain adverse development, excluding that related to most of the non-finite adverse development on loss reserves within the exited lines segment and all of the losses arising from the events of September 11, 2001, is subject to a cap of $12.0 million after-tax. Adverse development on the reserves excluded is not subject to any cap or limit. As of December 31, 2004, after giving effect to the $12.0 million cap referred to above, PXRE has incurred $34.1 million of net after-tax adverse development above this $7.0 million threshold, resulting in an adjusted conversion price of $13.40. Sixty-two percent of the convertible preferred shares mandatorily convert on March 31, 2005. These shares were originally scheduled to convert on April 4, 2005, but in the interest of presenting a balance sheet reflecting the conversion on March 31, PXRE reached an agreement with the preferred shareholders to convert four days early. All the remaining convertible preferred shares mandatorily convert by April 4, 2008. Convertible preferred shares vote on a fully converted basis on all matters brought before the shareholders other than the election of directors.
F-25
Under the terms of the preferred shares, the payment of dividends on the Company’s common shares is subject to the following limitations: (i) no dividend may be paid upon the common shares if the dividends payable upon the preferred shares are overdue, (ii) the amount of dividends paid with respect to the common shares may not be increased by a cumulative annualized rate of more than 10% at any time prior to April 4, 2005 (the “Permitted Dividend Amount”) without the consent of the majority of holders of the preferred shares; and (iii) at any time on or after April 4, 2005, no dividend may be paid that would result in payment of any dividend or other distribution with respect to common shares or result in a redemption, offer to purchase, tender offer or other acquisition of capital stock of the Company involving consideration having an aggregate fair value in excess of the greater of the Permitted Tender Offer Amount and the Permitted Dividend Amount. For this purpose, the term “Permitted Tender Offer Amount” means an amount equal to 20% of the cumulative amount by which consolidated net income in any calendar year commencing with the year ended December 31, 2002 exceeds $50.0 million minus the sum of all cash and the fair value of all non-cash consideration paid in respect of redemptions, offers to purchase, tender offers or other acquisitions of capital stock on or after December 10, 2001.
8. Statutory Information
The Insurance Department of the State of Connecticut and the Bermuda Monetary Authority, by which PXRE Reinsurance and PXRE Bermuda, respectively, are regulated, recognize as net income and surplus those amounts determined in conformity with statutory accounting principles (“SAP”) prescribed or permitted by those departments, which differ in certain respects from U.S. GAAP. The amounts of statutory capital and surplus at December 31, and statutory net income for the years ended December 31, 2004, 2003 and 2002, as filed with insurance regulatory authorities are as shown in the table below:
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
PXRE Reinsurance | | | | | | | | | | |
Statutory capital and surplus | | $ | 224,926 | | $ | 425,210 | | $ | 457,217 | |
Statutory net income | | $ | 3,206 | | $ | 32,838 | | $ | 39,517 | |
PXRE Bermuda | | | | | | | | | | |
Statutory capital and surplus | | $ | 749,084 | | $ | 425,839 | | $ | 70,609 | |
Statutory net income | | $ | 47,309 | | $ | 93,497 | | $ | 28,557 | |
During the year ended December 31, 2003, the Company contributed 42.6% of its ownership of PXRE Barbados to PXRE Bermuda, and during the year ended December 31, 2004, contributed the remaining portion. As a result of this transaction, as of December 31, 2004, PXRE Bermuda has an asset on its statutory balance sheet equal to $132.1 million, which upon consolidation is fully eliminated. The balance of the increase in statutory capital and surplus of PXRE Bermuda at December 31, 2004 was due to net income and contributions of capital from its parent.
PXRE Reinsurance is subject to state regulatory restrictions, which limit the maximum amount of annual dividends or other distributions, including loans or cash advances, available to shareholders without prior approval of the Insurance Commissioner of the State of Connecticut.
F-26
As of December 31, 2004, the maximum amount of dividends and other distributions, which may be made by PXRE Reinsurance during 2005 without prior approval, is limited to approximately $22.5 million. Accordingly, the remaining amount of its capital and surplus is considered restricted.
The payment of dividends by PXRE Bermuda is limited under Bermuda insurance laws, which require PXRE Bermuda to maintain certain measures of solvency and liquidity. As of December 31, 2004, the statutory capital and surplus of PXRE Bermuda was estimated to be $749.1 million and the amount required to be maintained was estimated to be $132.5 million.
Under Barbados law, PXRE Barbados may only pay a dividend out of the realized profits of the company. PXRE Barbados may not pay a dividend unless (a) it is able to pay its liabilities as they become due after payment of the dividend, (b) the realizable value of its assets is greater than the aggregate value of its liabilities, and (c) the stated capital accounts are maintained in respect of all classes of shares.
9. Earnings Per Share
A reconciliation of income before cumulative effect of accounting change to earnings, and shares, which affect basic and diluted earnings per share, is as follows:
(000’s, except per share data) | | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
Net income available to common shareholders: | | | | | | | | | | |
Income before cumulative effect of accounting change and convertible preferred share dividends | | $ | 23,899 | | $ | 96,648 | | $ | 64,545 | |
Cumulative effect of accounting change, net of tax | | | (1,053 | ) | | — | | | — | |
| |
|
| |
|
| |
|
| |
Net income before convertible preferred share dividends | | $ | 22,846 | | $ | 96,648 | | $ | 64,545 | |
| |
|
| |
|
| |
|
| |
Convertible preferred share dividends | | | 14,018 | | | 13,113 | | | 9,077 | |
| |
|
| |
|
| |
|
| |
Net income available to common shareholders | | $ | 8,828 | | $ | 83,535 | | $ | 55,468 | |
| |
|
| |
|
| |
|
| |
Weighted average common shares outstanding: | | | | | | | | | | |
Weighted average common shares outstanding (basic) | | | 14,433 | | | 11,992 | | | 11,802 | |
Equivalent shares of underlying options | | | 376 | | | 287 | | | 308 | |
Equivalent number of restricted shares | | | 180 | | | 132 | | | 143 | |
Equivalent number of convertible preferred shares | | | 12,756 | | | 11,164 | | | 7,409 | |
| |
|
| |
|
| |
|
| |
Weighted average common equivalent shares (diluted) | | | 27,745 | | | 23,575 | | | 19,662 | |
| |
|
| |
|
| |
|
| |
Per share amounts: | | | | | | | | | | |
Basic: | | | | | | | | | | |
Net income before cumulative effect of accounting change and convertible preferred share dividends | | $ | 1.65 | | $ | 8.06 | | $ | 5.47 | |
Net income available to common shareholders | | $ | 0.61 | | $ | 6.97 | | $ | 4.70 | |
Diluted: | | | | | | | | | | |
Net income before cumulative effect of accounting change | | $ | 0.86 | | $ | 4.10 | | $ | 3.28 | |
Net income | | $ | 0.82 | | $ | 4.10 | | $ | 3.28 | |
F-27
10. Employee Benefits
Benefit Plans
PXRE adopted a non-contributory defined benefit pension plan covering all U.S. employees with one year or more of service and who had attained age 21. Benefits are generally based on years of service and compensation. PXRE funds the plan in amounts not less than the minimum statutory funding requirement nor more than the maximum amount that can be deducted for U.S. income tax purposes.
PXRE also sponsors a supplemental executive retirement plan. This plan is non-qualified and provides certain key employees with benefits in excess of normal pension benefits.
Effective March 31, 2004, PXRE curtailed these pension plans and employees no longer accrue additional benefits thereunder.
The investment policy of the fund for the retirement plan seeks to manage the fund with a long term objective, of seven years or more, and achieve the highest practicable long-term rate of return without taking excessive risk that could jeopardize PXRE’s funding policy or subject PXRE to undue funding volatility. The objective of the investment policy is for the assets funded to achieve a rate of return over any seven year period that exceeds the rate of inflation by 5% after the cost of managing and administering the plan.
Asset allocations of the fund at December 31, 2004 and 2003 and the target allocation are as follows:
| | 2004 | | 2003 | | Target | |
| |
| |
| |
| |
Equity assets | | | 97 | % | | 82 | % | | 80%-100% | |
Fixed income assets | | | 3 | | | 18 | | | 0%-20% | |
| |
|
| |
|
| | | | |
| | | 100 | % | | 100 | % | | | |
| |
|
| |
|
| | | | |
The components of net pension expense for the company-sponsored plans for the years ended December 31, based on a January 1 valuation date (the latest actuarial estimate) are as follows:
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
Components of net periodic cost: | | | | | | | | | | |
Service cost | | $ | 303 | | $ | 978 | | $ | 984 | |
Interest cost | | | 354 | | | 555 | | | 648 | |
Expected return on assets | | | (352 | ) | | (430 | ) | | (197 | ) |
Amortization of prior service costs | | | 50 | | | 201 | | | 212 | |
Recognized net actuarial costs | | | 17 | | | (44 | ) | | — | |
Curtailments | | | (486 | ) | | — | | | — | |
Settlements | | | 666 | | | 598 | | | — | |
| |
|
| |
|
| |
|
| |
Net periodic benefit costs | | $ | 552 | | $ | 1,858 | | $ | 1,647 | |
| |
|
| |
|
| |
|
| |
F-28
The following table sets forth the funded status of the plans and amounts recognized in the Consolidated Balance Sheets:
($000’s) | | 2004 | | 2003 | |
| |
| |
| |
Reconciliation of benefit obligation | | | | | | | |
Benefit obligation as of January 1 | | $ | (8,371 | ) | $ | (11,020 | ) |
Service cost | | | (303 | ) | | (978 | ) |
Interest cost | | | (354 | ) | | (555 | ) |
Actuarial gain (loss) | | | (2,408 | ) | | (1,385 | ) |
Curtailments | | | 2,470 | | | — | |
Settlements | | | 2,713 | | | 5,567 | |
| |
|
| |
|
| |
Benefit obligation as of December 31 | | $ | (6,253 | ) | $ | (8,371 | ) |
| |
|
| |
|
| |
Reconciliation of plan assets | | | | | | | |
Fair value of plan assets as of January 1 | | $ | 5,317 | | $ | 4,740 | |
Return on plan assets | | | 663 | | | 1,043 | |
Employer contributions | | | 785 | | | 1,539 | |
Benefits paid | | | (2,713 | ) | | (2,005 | ) |
| |
|
| |
|
| |
Fair value of plan assets as of December 31 | | $ | 4,052 | | $ | 5,317 | |
| |
|
| |
|
| |
Reconciliation of funded status | | | | | | | |
Funded status | | $ | (2,201 | ) | $ | (3,054 | ) |
Unrecognized prior service cost | | | — | | | 1,490 | |
Unrecognized net loss | | | 2,045 | | | 1,176 | |
| |
|
| |
|
| |
Accrued cost | | $ | (156 | ) | $ | (388 | ) |
| |
|
| |
|
| |
Weighted average assumptions as of December 31: | | | | | | | |
Discount rate | | | 5.75 | % | | 6.25 | % |
Expected return on plan assets | | | 8.00 | % | | 8.00 | % |
Rate of compensation increase | | | NA | | | 5.00 | % |
The following table sets forth the expected future benefit payments.
($000’s) | | | | | |
| |
| |
| 2005 | | $ | 1,484 | |
| 2006 | | | — | |
| 2007 | | | — | |
| 2008 | | | 1,643 | |
| 2009 | | | 118 | |
Years | 2010 - 2014 | | | 989 | |
The Company expects no significant contributions during 2005.
During 2004, there were settlements with three former employees with respect to their vested benefits in which lump sum cash payments were made to these plan participants in exchange for their rights to receive specified pension benefits. During 2003, there were settlements upon retirement of the Company’s former Chief Executive Officer and two former employees with respect to their vested benefits in which lump sum cash payments were made to these plan participants in exchange for their rights to receive specified pension benefits.
F-29
PXRE sponsors a defined contribution plan covering all employees with three months or more of service. PXRE matches 100% of each employee’s contribution, subject to a maximum of 5% of salary. In addition, PXRE may contribute profit-sharing up to 3% of each employee’s salary. During 2004, 2003 and 2002 PXRE incurred expenses from this plan of $0.7 million, $0.5 million and $0.4 million, respectively.
Employee Share Purchase Plan
PXRE maintains an Employee Share Purchase Plan under which it has reserved 0.1 million common shares for issuance to PXRE personnel. On the first Monday of each calendar quarter (the “Grant Date”), plan participants can enter into an agreement to purchase shares on the first Monday of the next calendar quarter (the “Exercise Date”). The purchase price is the lesser of 85% of the fair market value of PXRE’s common shares on the Grant Date or the Exercise Date.
11. Stock Compensation
In February 2004, the Board of Directors approved the adoption of the PXRE Group’s Annual Incentive Bonus Compensation Plan (the “2004 Bonus Plan”). As approved by PXRE’s shareholders, awards will be granted under the Bonus Plan with respect to performance on a number of criteria compared to target criteria, including return on equity, certain expense ratios and reserve adequacy as well as a discretionary component related to individual performance. Under the 2004 Bonus Plan, bonuses are paid in cash up to the amount of each employees target bonus. For certain senior executives and above, 30% of any bonus amount in excess of target bonus is paid in restricted shares which cliff vest after 3 years.
Prior to the adoption of the 2004 Bonus Plan, the Company provided annual bonus compensation to employees through the Restated Employee Annual Incentive Bonus Plan (the “Terminated Bonus Plan”). Under the Terminated Bonus Plan, incentive compensation to employees was based in part on return on equity compared to a target return on equity and in part at the discretion of the Restated Bonus Plan Committee. The Restated Employee Annual Incentive Bonus Plan was terminated effective December 31, 2003. The maximum compensation paid in any year was limited to 150% of target bonuses under the Plan. Amounts incurred above 150% of target up to a maximum award at 240% of target represented contingent incentive compensation. In each of 2003 and 2002, the bonus percentage under the Restated Employee Annual Incentive Bonus Plan exceeded 150% and the portion of the bonus in excess of 150% of the target bonus was deferred in accordance with the terms of such plan. Commencing in March 2004, the Human Resources Committee determined to pay out such deferred amounts in three equal annual installments to officers and in a single lump sum for non-officers. At December 31, 2004, the amount of the contingent liability was $1.0 million. In addition, 30% of all bonus amounts paid to officers under the Terminated Bonus Plan were paid in restricted shares that cliff vest after 3 years.
F-30
The Company awards long term equity compensation pursuant to its 1992 and 2002 Officer Incentive Plan, which provides for the grant of incentive share options, non-qualified share options and awards of shares subject to certain restrictions. Options granted under the plan have a term of 10 years and generally become exercisable in four equal annual installments commencing one year from the date of grant. The exercise price for the incentive share options must be equal to or exceed the fair market value of the common shares on the date the option is granted. The exercise price for the non-qualified options may not be less than the fair market value of the common stock on the date of grant. At December 31, 2004 and 2003, options for 1,172,306 and 1,178,989 shares, respectively, were exercisable under these plans.
In 2004, 2003 and 2002, $7.0 million, $7.7 million and $6.3 million, respectively were incurred under these plans, including bonuses granted to certain levels of employees paid in restricted shares, which vest at the end of 3 years or at each annual anniversary date over 4 years.
Information regarding the employee option plans described above is as follows:
| | Number of Shares | | Range – Option Price per Share | |
| |
| |
| |
Outstanding at December 31, 2001 | | | 1,642,609 | | | | |
Options granted | | | 538,238 | | | $17.45 - $24.17 | |
Options exercised | | | (126,214 | ) | | $10.88 - $19.80 | |
Options forfeited | | | (73,934 | ) | | $12.50 - $32.94 | |
| |
|
| | | | |
Outstanding at December 31, 2002 | | | 1,980,699 | | | | |
| |
|
| | | | |
Options granted | | | 374,773 | | | $19.88 - $23.78 | |
Options exercised | | | (60,625 | ) | | $12.50 - $19.80 | |
Options forfeited | | | (47,248 | ) | | $12.50 - $32.94 | |
| |
|
| | | | |
Outstanding at December 31, 2003 | | | 2,247,599 | | | | |
| |
|
| | | | |
Options granted | | | — | | | N/A | |
Options exercised | | | (530,468 | ) | | $12.50 - $26.69 | |
Options forfeited | | | (48,759 | ) | | $15.95 - $32.94 | |
| |
|
| | | | |
Outstanding at December 31, 2004 | | | 1,668,372 | | | | |
| |
|
| | | | |
PXRE has adopted a non-employee Director Stock Plan, which provides for an annual grant of 5,000 options and 1,000 restricted shares per non-employee director from 2000 to 2003 and 5,000 options and 2,500 restricted shares per director from 2004. Restricted shares vest at each annual anniversary date over 3 years. Options granted under the plan have a term of 10 years from the date of grant and are exercisable in three equal annual installments commencing one year from the date of grant. The exercise price of the options is the fair market value on the date of grant. As of December 31, 2004, options for 500,000 shares were authorized, 254,667 were outstanding and 159,217 were exercisable, at exercise prices between $14.79 and $31.11.
PXRE allows its directors to elect to convert their Board of Directors retainer fee to options under the Directors Equity and Deferred Compensation Plan. At December 31, 2004, options for 250,000 shares were authorized and 106,177 were outstanding at prices ranging from $12.81 to $33.46 which are 100% vested and immediately exercisable for a period of 10 years.
As of December 31, 2004, total authorized common shares reserved for grants of employee and director share options and restricted shares under the above plans are 3,324,401 shares. Total shares of 1,437,700 relate to share options which are vested and exercisable at December 31, 2004 at exercise prices between $12.50 and $33.46. All options become exercisable upon a change of control of PXRE as defined by the plans.
F-31
As permitted by SFAS No. 123, PXRE has elected to continue to account for its share option plans under the accounting rules prescribed by APB 25, under which no compensation costs are recognized as an expense. Had compensation costs for the share options been determined using the fair value method of accounting as recommended by SFAS No. 123, net income and earnings per share for 2004, 2003 and 2002 would have been reduced to the following pro-forma amounts:
($000’s, except per share data) | | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
Net income before convertible preferred share dividends: | | | | | | | | | | |
As reported | | $ | 22,846 | | $ | 96,648 | | $ | 64,545 | |
| |
|
| |
|
| |
|
| |
Deduct: | | | | | | | | | | |
Total share-based compensation expense determined under fair value based method for all awards, net of related tax effects | | | (2,180 | ) | | (2,927 | ) | | (2,464 | ) |
| |
|
| |
|
| |
|
| |
Pro-forma | | $ | 20,666 | | $ | 93,721 | | $ | 62,081 | |
| |
|
| |
|
| |
|
| |
Basic income per share: | | | | | | | | | | |
As reported | | $ | 0.61 | | $ | 6.97 | | $ | 4.70 | |
Pro-forma | | $ | 0.46 | | $ | 6.72 | | $ | 4.49 | |
Diluted income per share: | | | | | | | | | | |
As reported | | $ | 0.82 | | $ | 4.10 | | $ | 3.28 | |
Pro-forma | | $ | 0.74 | | $ | 3.98 | | $ | 3.16 | |
The fair value of each option granted in 2004, 2003 and 2002 was estimated on the date of grant using a modified Black-Scholes option pricing model with the following weighted average assumptions:
| | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
Risk-free rate | | | 3.73 | % | | 2.94 | % | | 4.23 | % |
Dividend yield | | | 0.99 | % | | 1.06 | % | | 1.29 | % |
Volatility factor | | | 40.72 | % | | 40.49 | % | | 40.43 | % |
Expected life (in years) | | | 5 | | | 5 | | | 5 | |
A summary of the status of the employee and director share option plans at December 31, 2004 and 2003 and changes during the years then ended is presented below:
| | 2004 | | 2003 | |
| |
| |
| |
| | Shares | | Weighted Average Exercise Price | | Shares | | Weighted Average Exercise Price | |
| |
| |
| |
| |
| |
Options outstanding at beginning of year | | | 2,606,649 | | $ | 19.19 | | | 2,319,802 | | $ | 18.49 | |
Options granted | | | 51,095 | | | 24.20 | | | 435,081 | | | 22.69 | |
Options exercised | | | (579,769 | ) | | 16.83 | | | (64,958 | ) | | 13.55 | |
Options forfeited | | | (48,759 | ) | | 21.83 | | | (83,276 | ) | | 22.18 | |
| |
|
| | | | |
|
| | | | |
Options outstanding at end of year | | | 2,029,216 | | | 19.93 | | | 2,606,649 | | | 19.19 | |
| |
|
| | | | |
|
| | | | |
Options exercisable at end of year | | | 1,437,700 | | | 19.78 | | | 1,453,256 | | | 19.38 | |
| |
|
| | | | |
|
| | | | |
Weighted average fair value of options granted | | | | | | 9.19 | | | | | | 8.21 | |
F-32
Employee and director options outstanding at December 31, 2004 included:
Range of Exercise Prices | | Number Outstanding at December 31, 2004 | | Weighted Average Remaining Life | | Weighted Average Exercise Price | | Number Exercisable at December 31, 2004 | | Weighted Average Exercise Price | |
| |
| |
| |
| |
| |
| |
$12.50 to $20.70 | | | 1,342,635 | | | 6.73 | | $ | 17.10 | | | 953,719 | | $ | 16.55 | |
$22.49 to $33.46 | | | 686,581 | | | 5.76 | | $ | 25.47 | | | 483,981 | | $ | 26.13 | |
| |
|
| | | | | | | |
|
| | | | |
| | | 2,029,216 | | | | | | | | | 1,437,700 | | | | |
| |
|
| | | | | | | |
|
| | | | |
PXRE also had adopted a non-employee Director Deferred Share Plan granting 2,000 shares to each non-employee Board member prior to 2003 at the times specified in the plan. This plan was terminated effective January 1, 2003. At December 31, 2004, the 14,000 shares granted to eligible non-employee Board members will be issued to Board members at their termination.
12. Segment Information
PXRE operates in two reportable property and casualty segments – (i) catastrophe and risk excess and (ii) exited lines – based on PXRE’s approach to managing the business. Commencing with the 2002 underwriting renewal season, PXRE returned its focus to its core property catastrophe and risk excess business. Businesses that were not renewed in 2002 are reported as exited lines. Commencing with the 2004 underwriting renewal season, PXRE is reporting its previously existing “other lines” segment, which in the past has consisted of a single pro rata treaty, with its catastrophe and risk excess segment. In addition, PXRE is reporting its previously existing “finite business” segment with its exited lines segment to reflect its decision during the second quarter to run-off the in-force finite business and not enter into any new finite transactions subsequent to March 31, 2004. PXRE’s segments for 2003 and 2002 were restated to be comparable to the two 2004 segments discussed above. As a result of the above, the exited lines segment now includes business previously written and classified by the Company as direct casualty, Lloyd’s of London (“Lloyd’s”), international casualty and finite. In addition, PXRE operates in two geographic segments – North American, representing North American based risks written by North American based clients, and International (principally the United Kingdom, Continental Europe, Latin America, the Caribbean, Australia and Asia), representing all other premiums written.
There are no differences among the accounting policies of the segments as compared to PXRE’s consolidated financial statements.
PXRE does not maintain separate balance sheet data for each of its operating segments nor does it allocate net investment income, net realized investment gains or losses, interest expense, operating expenses, and foreign exchange gains and losses to these segments. Accordingly, PXRE does not review and evaluate the financial results of its operating segments based upon balance sheet data and these other income statement items.
The following tables summarize the net premiums written and net premiums earned by PXRE’s business segments. The amounts shown for the North American and International geographic segments are presented net of proportional reinsurance and allocated excess of loss reinsurance cessions, but gross of corporate catastrophe excess of loss reinsurance cessions, which are separately itemized where applicable.
F-33
Net Premiums Written
| | Year Ended December 31, | |
| |
| |
| | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
($000’s except percentages) | | Amount | | Percent | | Amount | | Percent | | Amount | | Percent | |
| |
| |
| |
| |
| |
| |
| |
Catastrophe and Risk Excess | | | | | | | | | | | | | | | | | | | |
North American | | $ | 85,661 | | | | | $ | 72,976 | | | | | $ | 60,843 | | | | |
International | | | 250,505 | | | | | | 225,469 | | | | | | 156,161 | | | | |
Excess of Loss Cessions | | | (28,729 | ) | | | | | (32,222 | ) | | | | | (33,056 | ) | | | |
| |
|
| | | | |
|
| | | | |
|
| | | | |
| | | 307,437 | | | 99 | % | | 266,223 | | | 96 | % | | 183,948 | | | 62 | % |
| |
|
| | | | |
|
| | | | |
|
| | | | |
Exited Lines | | | | | | | | | | | | | | | | | | | |
North American | | | 2,469 | | | | | | 9,061 | | | | | | 111,255 | | | | |
International | | | (119 | ) | | | | | 3,127 | | | | | | (720 | ) | | | |
| |
|
| | | | |
|
| | | | |
|
| | | | |
| | | 2,350 | | | 1 | | | 12,188 | | | 4 | | | 110,535 | | | 38 | |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Total | | $ | 309,787 | | | 100 | % | $ | 278,411 | | | 100 | % | $ | 294,483 | | | 100 | % |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Net Premiums Earned
| | Year Ended December 31, | |
| |
| |
| | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
($000’s except percentages) | | Amount | | Percent | | Amount | | Percent | | Amount | | Percent | |
| |
| |
| |
| |
| |
| |
| |
Catastrophe and Risk Excess | | | | | | | | | | | | | | | | | | | |
North American | | $ | 87,109 | | | | | $ | 72,178 | | | | | $ | 59,853 | | | | |
International | | | 249,365 | | | | | | 222,112 | | | | | | 151,833 | | | | |
Excess of Loss Cessions | | | (34,655 | ) | | | | | (32,227 | ) | | | | | (27,456 | ) | | | |
| |
|
| | | | |
|
| | | | |
|
| | | | |
| | | 301,819 | | | 98 | % | | 262,063 | | | 82 | % | | 184,230 | | | 68 | % |
| |
|
| | | | |
|
| | | | |
|
| | | | |
Exited Lines | | | | | | | | | | | | | | | | | | | |
North American | | | 6,374 | | | | | | 55,671 | | | | | | 75,951 | | | | |
International | | | (121 | ) | | | | | 3,199 | | | | | | 9,179 | | | | |
| |
|
| | | | |
|
| | | | |
|
| | | | |
| | | 6,253 | | | 2 | | | 58,870 | | | 18 | | | 85,130 | | | 32 | |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Total | | $ | 308,072 | | | 100 | % | $ | 320,933 | | | 100 | % | $ | 269,360 | | | 100 | % |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
F-34
The following table summarizes the underwriting income by segment. The amounts shown in the North American and International geographic segments are presented net of proportional reinsurance and allocated excess of loss reinsurance cessions, but gross of corporate catastrophe excess of loss reinsurance cessions, which are separately itemized where applicable. Underwriting income includes premiums earned, losses incurred and commission and brokerage net of fee income, but does not include investment income, net realized investment gains or losses, interest expense, operating expenses or foreign exchange gains or losses.
Underwriting Income
| | Year Ended December 31, | |
| |
| |
| | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
($000’s, except percentages) | | Amount | | Percent | | Amount | | Percent | | Amount | | Percent | |
| |
| |
| |
| |
| |
| |
| |
Catastrophe and Risk Excess | | | | | | | | | | | | | | | | | | | |
North American | | $ | 36,793 | | | | | $ | 41,702 | | | | | $ | 49,381 | | | | |
International | | | 63,686 | | | | | | 152,950 | | | | | | 83,849 | | | | |
Excess of Loss Cessions | | | (30,287 | ) | | | | | (34,663 | ) | | | | | (19,286 | ) | | | |
| |
|
| | | | |
|
| | | | |
|
| | | | |
| | | 70,192 | | | 148 | % | | 159,989 | | | 132 | % | | 113,944 | | | 121 | % |
| |
|
| | | | |
|
| | | | |
|
| | | | |
Exited Lines | | | | | | | | | | | | | | | | | | | |
North American | | | (26,873 | ) | | | | | (31,834 | ) | | | | | (17,738 | ) | | | |
International | | | 4,080 | | | | | | (7,146 | ) | | | | | (2,075 | ) | | | |
| |
|
| | | | |
|
| | | | |
|
| | | | |
| | | (22,793 | ) | | (48 | ) | | (38,980 | ) | | (32 | ) | | (19,813 | ) | | (21 | ) |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Total | | $ | 47,399 | | | 100 | % | $ | 121,009 | | | 100 | % | $ | 94,131 | | | 100 | % |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Included in the exited lines segment in 2002 were net premiums written of $83.8 million and underwriting income of $3.0 million pursuant to various exited finite reinsurance contracts with Tower Insurance Company of New York (“Tower”). In 2004 and 2003, there were no net premiums written related to Tower.
The following table reconciles the underwriting income for the operating segments to income before taxes, cumulative effect of accounting change and convertible preferred share dividends as reported in the Consolidated Statements of Income and Comprehensive Income:
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
Net underwriting income | | $ | 47,399 | | $ | 121,009 | | $ | 94,131 | |
Net investment income | | | 26,178 | | | 26,931 | | | 24,893 | |
Net realized investment (losses) gains | | | (150 | ) | | 2,447 | | | 8,981 | |
Other operating expenses | | | (41,293 | ) | | (39,701 | ) | | (34,228 | ) |
Foreign exchange (losses) gains | | | (80 | ) | | (143 | ) | | 273 | |
Interest expense | | | (14,389 | ) | | (2,506 | ) | | (2,939 | ) |
Minority interest in consolidated subsidiaries | | | — | | | (10,528 | ) | | (8,646 | ) |
Other loss | | | — | | | (20 | ) | | (91 | ) |
| |
|
| |
|
| |
|
| |
Income before income taxes, cumulative effect of accounting change and convertible preferred share dividends | | $ | 17,665 | | $ | 97,489 | | $ | 82,374 | |
| |
|
| |
|
| |
|
| |
F-35
13. Quarterly Consolidated Results of Operations (Unaudited)
The following are unaudited quarterly results of operations on a consolidated basis for the years ended December 31, 2004 and 2003. Quarterly results necessarily rely heavily on estimates. This and certain other factors, such as catastrophic losses, call for caution in drawing specific conclusions from quarterly results. Due to changes in the number of average shares outstanding, quarterly earnings per share may not add to the total for the year.
| | Three Months Ended | |
| |
| |
($000’s, except per share data) | | March 31 | | June 30 | | September 30 | | December 31 | |
| |
| |
| |
| |
| |
2004 | | | | | | | | | | | | | |
Net premiums written | | $ | 89,712 | | $ | 51,224 | | $ | 112,591 | | $ | 56,260 | |
| |
|
| |
|
| |
|
| |
|
| |
Revenues: | | | | | | | | | | | | | |
Net premiums earned | | $ | 68,952 | | $ | 69,565 | | $ | 89,799 | | $ | 79,756 | |
Net investment income | | | 6,869 | | | 4,915 | | | 5,157 | | | 9,237 | |
Net realized investment gains (losses) | | | 89 | | | (38 | ) | | (40 | ) | | (161 | ) |
Fee income | | | 599 | | | 262 | | | 695 | | | 229 | |
| |
|
| |
|
| |
|
| |
|
| |
Total revenues | | | 76,509 | | | 74,704 | | | 95,611 | | | 89,061 | |
| |
|
| |
|
| |
|
| |
|
| |
Losses and expenses: | | | | | | | | | | | | | |
Losses and loss expenses incurred | | | 18,139 | | | 18,077 | | | 156,335 | | | 33,796 | |
Commissions and brokerage | | | 9,172 | | | 10,214 | | | 8,900 | | | 7,825 | |
Operating expenses | | | 12,620 | | | 9,868 | | | 8,272 | | | 10,533 | |
Foreign exchange losses (gains) | | | 266 | | | 94 | | | (382 | ) | | 102 | |
Interest expense | | | 3,675 | | | 3,455 | | | 3,817 | | | 3,442 | |
| |
|
| |
|
| |
|
| |
|
| |
Total losses and expenses | | | 43,872 | | | 41,708 | | | 176,942 | | | 55,698 | |
| |
|
| |
|
| |
|
| |
|
| |
Income (loss) before income taxes, cumulative effect of accounting change and convertible preferred share dividends | | | 32,637 | | | 32,996 | | | (81,331 | ) | | 33,363 | |
Income tax provision (benefit) | | | 653 | | | 660 | | | (8,157 | ) | | 610 | |
| |
|
| |
|
| |
|
| |
|
| |
Income (loss) before cumulative effect of accounting change and convertible preferred share dividends | | | 31,984 | | | 32,336 | | | (73,174 | ) | | 32,753 | |
Cumulative effect of accounting change, net of $0.2 million tax benefit | | | (1,053 | ) | | — | | | — | | | — | |
| |
|
| |
|
| |
|
| |
|
| |
Net income (loss) before convertible preferred share dividends | | $ | 30,931 | | $ | 32,336 | | $ | (73,174 | ) | $ | 32,753 | |
| |
|
| |
|
| |
|
| |
|
| |
Convertible preferred share dividends | | | 3,444 | | | 3,513 | | | 3,583 | | | 3,478 | |
| |
|
| |
|
| |
|
| |
|
| |
Net income (loss) available to common shareholders | | $ | 27,487 | | $ | 28,823 | | $ | (76,757 | ) | $ | 29,275 | |
| |
|
| |
|
| |
|
| |
|
| |
Basic earnings per common share: | | | | | | | | | | | | | |
Net income (loss) available to common shareholders | | $ | 2.04 | | $ | 2.09 | | $ | (5.48 | ) | $ | 1.78 | |
| |
|
| |
|
| |
|
| |
|
| |
Average shares outstanding (000’s) | | | 13,417 | | | 13,822 | | | 13,995 | | | 16,444 | |
| |
|
| |
|
| |
|
| |
|
| |
Diluted earnings per common share: | | | | | | | | | | | | | |
Net income (loss) | | $ | 1.18 | | $ | 1.20 | | $ | (5.48 | ) | $ | 1.09 | |
| |
|
| |
|
| |
|
| |
|
| |
Average shares outstanding (000’s) | | | 26,282 | | | 27,021 | | | 13,995 | | | 29,938 | |
| |
|
| |
|
| |
|
| |
|
| |
Dividends paid per common share | | $ | 0.06 | | $ | 0.06 | | $ | 0.06 | | $ | 0.06 | |
F-36
| | Three Months Ended | |
| |
| |
($000’s, except per share data) | | March 31 | | June 30 | | September 30 | | December 31 | |
| |
| |
| |
| |
| |
2003 | | | | | | | | | | | | | |
Net premiums written | | $ | 93,344 | | $ | 58,045 | | $ | 70,042 | | $ | 56,980 | |
| |
|
| |
|
| |
|
| |
|
| |
Revenues: | | | | | | | | | | | | | |
Net premiums earned | | $ | 84,772 | | $ | 84,015 | | $ | 69,082 | | $ | 83,063 | |
Net investment income | | | 5,475 | | | 8,557 | | | 5,994 | | | 6,906 | |
Net realized investment (losses) gains | | | (1 | ) | | 110 | | | 502 | | | 1,836 | |
Fee income | | | 1,276 | | | 1,108 | | | 1,148 | | | 1,481 | |
| |
|
| |
|
| |
|
| |
|
| |
Total revenues | | | 91,522 | | | 93,790 | | | 76,726 | | | 93,286 | |
| |
|
| |
|
| |
|
| |
|
| |
Losses and expenses: | | | | | | | | | | | | | |
Losses and loss expenses incurred | | | 32,599 | | | 44,654 | | | 35,245 | | | 45,098 | |
Commissions and brokerage | | | 20,027 | | | 14,618 | | | 3,218 | | | 9,497 | |
Operating expenses | | | 9,176 | | | 10,488 | | | 9,788 | | | 10,252 | |
Foreign exchange losses (gains) | | | 241 | | | (492 | ) | | 927 | | | (534 | ) |
Interest expense | | | 2,259 | | | 245 | | | — | | | — | |
Minority interest in consolidated subsidiaries | | | 2,106 | | | 2,428 | | | 2,817 | | | 3,179 | |
| |
|
| |
|
| |
|
| |
|
| |
Total losses and expenses | | | 66,408 | | | 71,941 | | | 51,995 | | | 67,492 | |
| |
|
| |
|
| |
|
| |
|
| |
Income before income taxes and convertible preferred share dividends | | | 25,114 | | | 21,849 | | | 24,731 | | | 25,794 | |
Income tax provision (benefit) | | | 1,507 | | | 371 | | | 1,007 | | | (2,046 | ) |
| |
|
| |
|
| |
|
| |
|
| |
Net income before convertible preferred share dividends | | $ | 23,607 | | $ | 21,478 | | $ | 23,724 | | $ | 27,840 | |
| |
|
| |
|
| |
|
| |
|
| |
Convertible preferred share dividends | | | 3,182 | | | 3,245 | | | 3,310 | | | 3,376 | |
| |
|
| |
|
| |
|
| |
|
| |
Net income available to common shareholders | | $ | 20,425 | | $ | 18,233 | | $ | 20,414 | | $ | 24,464 | |
| |
|
| |
|
| |
|
| |
|
| |
Basic earnings per common share: | | | | | | | | | | | | | |
Net income available to common shareholders | | $ | 1.71 | | $ | 1.53 | | $ | 1.71 | | $ | 2.02 | |
| |
|
| |
|
| |
|
| |
|
| |
Average shares outstanding (000’s) | | | 11,894 | | | 11,921 | | | 11,925 | | | 12,123 | |
| |
|
| |
|
| |
|
| |
|
| |
Diluted earnings per common share: | | | | | | | | | | | | | |
Net income | | $ | 1.04 | | $ | 0.93 | | $ | 1.01 | | $ | 1.14 | |
| |
|
| |
|
| |
|
| |
|
| |
Average shares outstanding (000’s) | | | 22,664 | | | 23,183 | | | 23,583 | | | 24,462 | |
| |
|
| |
|
| |
|
| |
|
| |
Dividends paid per common share | | $ | 0.06 | | $ | 0.06 | | $ | 0.06 | | $ | 0.06 | |
F-37
PARENT COMPANY INFORMATION | Schedule II |
PXRE Group Ltd.’s summarized financial information (parent company only) is as follows:
($000’s) | | December 31, 2004 | | December 31, 2003 | |
| |
| |
| |
BALANCE SHEETS | | | | | | | |
Assets: | | | | | | | |
Cash | | $ | 214 | | $ | 155 | |
Short-term investments | | | — | | | 1,099 | |
Fixed maturities | | | — | | | — | |
Receivable from subsidiaries | | | 1,774 | | | — | |
Note receivable from subsidiary | | | — | | | 4 | |
Equity in subsidiaries | | | 756,697 | | | 624,635 | |
Other assets | | | 5,345 | | | 3,374 | |
| |
|
| |
|
| |
Total assets | | $ | 764,030 | | $ | 629,267 | |
| |
|
| |
|
| |
Liabilities: | | | | | | | |
Liabilities to subsidiary | | $ | — | | $ | 292 | |
Other liabilities | | | 3,040 | | | 1,959 | |
Minority interest in consolidated subsidiaries | | | — | | | 62,500 | |
Subordinated debt | | | 64,435 | | | — | |
| |
|
| |
|
| |
Total liabilities | | | 67,475 | | | 64,751 | |
| |
|
| |
|
| |
Shareholders’ equity | | | 696,555 | | | 564,516 | |
| |
|
| |
|
| |
Total liabilities and shareholders’ equity | | $ | 764,030 | | $ | 629,267 | |
| |
|
| |
|
| |
| | Years Ended December 31, | |
| |
| |
($000’s) | | 2004 | | 2003 | | 2002 | |
| |
| |
| |
| |
INCOME STATEMENTS | | | | | | | | | | |
Net investment income | | $ | 131 | | $ | 3,662 | | $ | 6,614 | |
Fee income | | | — | | | 22 | | | 94 | |
Minority interest in consolidated subsidiaries | | | — | | | (1,795 | ) | | — | |
Interest expense | | | (5,289 | ) | | — | | | — | |
Other operating expenses | | | (8,015 | ) | | (5,725 | ) | | (4,201 | ) |
| |
|
| |
|
| |
|
| |
(Loss) income before equity in earnings of subsidiary and cumulative effect of accounting change | | | (13,173 | ) | | (3,836 | ) | | 2,507 | |
Equity in earnings of subsidiary | | | 37,072 | | | 100,484 | | | 62,039 | |
| |
|
| |
|
| |
|
| |
Income before cumulative effect of accounting change | | | 23,899 | | | 96,648 | | | 64,546 | |
Cumulative effect of accounting change, net of tax | | | (1,053 | ) | | — | | | — | |
| |
|
| |
|
| |
|
| |
Net income | | $ | 22,846 | | $ | 96,648 | | $ | 64,546 | |
| |
|
| |
|
| |
|
| |
CASH FLOW STATEMENTS | | | | | | | | | | |
Cash flows from operating activities: | | | | | | | | | | |
Net income | | $ | 22,846 | | $ | 96,648 | | $ | 64,546 | |
Adjustments to reconcile net income to cash (used) provided by operating activities: | | | | | | | | | | |
Equity in earnings of subsidiaries | | | (37,072 | ) | | (100,484 | ) | | (62,039 | ) |
Inter-company accounts | | | (2,066 | ) | | 3,332 | | | (3,631 | ) |
Other | | | 6,006 | | | 874 | | | 3,216 | |
| |
|
| |
|
| |
|
| |
Net cash (used) provided by operating activities | | | (10,286 | ) | | 370 | | | 2,092 | |
| |
|
| |
|
| |
|
| |
Cash flows from investing activities: | | | | | | | | | | |
Net change in short-term investments | | | 1,099 | | | 2,174 | | | (3,273 | ) |
Fixed maturities disposed or matured | | | — | | | 505 | | | — | |
Contribution of capital to subsidiaries | | | (100,982 | ) | | (177,249 | ) | | (140,000 | ) |
Notes to subsidiaries | | | 4 | | | 94,752 | | | 1,596 | |
| |
|
| |
|
| |
|
| |
Net cash used by investing activities | | | (99,879 | ) | | (79,818 | ) | | (141,677 | ) |
| |
|
| |
|
| |
|
| |
Cash flows from financing activities: | | | | | | | | | | |
Proceeds from issuance of common shares | | | 114,701 | | | 21,538 | | | 2,129 | |
Proceeds from issuance of convertible preferred shares | | | — | | | — | | | 140,888 | |
Proceeds from issuance of minority interest in consolidated subsidiaries | | | — | | | 62,500 | | | — | |
Cash dividends paid to common shareholders | | | (3,417 | ) | | (2,927 | ) | | (2,879 | ) |
Cost of shares repurchased | | | (1,060 | ) | | (1,848 | ) | | (529 | ) |
| |
|
| |
|
| |
|
| |
Net cash provided by financing activities | | | 110,224 | | | 79,263 | | | 139,609 | |
| |
|
| |
|
| |
|
| |
Net change in cash | | | 59 | | | (185 | ) | | 24 | |
Cash, beginning of year | | | 155 | | | 340 | | | 316 | |
| |
|
| |
|
| |
|
| |
Cash, end of year | | $ | 214 | | $ | 155 | | $ | 340 | |
| |
|
| |
|
| |
|
| |
Supplemental disclosure of non cash flow information: | | | | | | | | | | |
Reduction of note receivable from subsidiary and contribution to capital of subsidiary | | $ | — | | $ | 43,393 | | $ | — | |
| |
|
| |
|
| |
|
| |
Deconsolidation increase of subordinated debt investments – Other assets and Subordinated debt | | $ | 1,935 | | $ | — | | $ | — | |
| |
|
| |
|
| |
|
| |
Convertible preferred share dividends | | $ | 14,018 | | $ | 13,133 | | $ | 9,077 | |
| |
|
| |
|
| |
|
| |
F-38
Schedule III
PXRE GROUP LTD. AND SUBSIDIARIES
SUPPLEMENTARY INSURANCE INFORMATION
| ($000’s) Column A | | Column B | | Column C | | Column D | | Column E | | Column F | |
|
| |
| |
| |
| |
| |
| |
| Segment-property and casualty insurance | | Deferred policy acquisition cost (caption 7) | | Future policy benefits, losses, claims and loss expenses (caption 13-a-1) | | Assumed unearned premiums (caption 13-a-2) | | Other policy claims and benefits payable (caption 13-a-3) | | Premium revenue (caption 1) | |
|
| |
| |
| |
| |
| |
| |
2004 | North American | | | | | | | | | | | | | | $ | 93,483 | |
| International | | | | | | | | | | | | | | | 249,244 | |
| Corporate Wide | | | | | | | | | | | | | | | (34,655 | ) |
| | |
|
| |
|
| |
|
| |
|
| |
|
| |
| Total | | $ | 1,745 | | $ | 460,084 | | $ | 15,952 | | $ | — | | $ | 308,072 | |
2003 | North American | | | | | | | | | | | | | | $ | 127,849 | |
| International | | | | | | | | | | | | | | | 225,311 | |
| Corporate Wide | | | | | | | | | | | | | | | (32,227 | ) |
| | |
|
| |
|
| |
|
| |
|
| |
|
| |
| Total | | $ | 2,495 | | $ | 450,635 | | $ | 21,566 | | $ | — | | $ | 320,933 | |
2002 | North American | | | | | | | | | | | | | | $ | 135,804 | |
| International | | | | | | | | | | | | | | | 161,012 | |
| Corporate Wide | | | | | | | | | | | | | | | (27,456 | ) |
| | |
|
| |
|
| |
|
| |
|
| |
|
| |
| Total | | $ | 22,721 | | $ | 447,829 | | $ | 63,756 | | $ | — | | $ | 269,360 | |
| ($000’s) Column A | | Column G | | Column H | | Column I | | Column J | | Column K | |
|
| |
| |
| |
| |
| |
| |
| Segment-property and casualty insurance | | Net investment income (caption 2) | | Benefits, claims, losses and settlement expenses (caption 4) | | Amortization of deferred policy acquisition costs | | Other operating expense | | Premiums written | |
|
| |
| |
| |
| |
| |
| |
2004 | North American | | | | | $ | 71,833 | | $ | 11,730 | | | | | $ | 88,130 | |
| International | | | | | | 159,163 | | | 22,315 | | | | | | 250,386 | |
| Corporate Wide | | | | | | (4,649 | ) | | 281 | | | | | | (28,729 | ) |
| | |
|
| |
|
| |
|
| |
|
| |
|
| |
| Total | | $ | 26,178 | | $ | 226,347 | | $ | 34,326 | | $ | 41,293 | | $ | 309,787 | |
2003 | North American | | | | | $ | 98,996 | | $ | 18,985 | | | | | $ | 82,037 | |
| International | | | | | | 59,228 | | | 20,279 | | | | | | 228,596 | |
| Corporate Wide | | | | | | (626 | ) | | 3,062 | | | | | | (32,222 | ) |
| | |
|
| |
|
| |
|
| |
|
| |
|
| |
| Total | | $ | 26,931 | | $ | 157,598 | | $ | 42,326 | | $ | 39,701 | | $ | 278,411 | |
2002 | North American | | | | | $ | 68,663 | | $ | 35,498 | | | | | $ | 172,098 | |
| International | | | | | | 61,100 | | | 18,138 | | | | | | 155,441 | |
| Corporate Wide | | | | | | (4,402 | ) | | (3,768 | ) | | | | | (33,056 | ) |
| | |
|
| |
|
| |
|
| |
|
| |
|
| |
| Total | | $ | 24,893 | | $ | 125,361 | | $ | 49,868 | | $ | 34,228 | | $ | 294,483 | |
F-39
Schedule V
PXRE GROUP LTD. AND SUBSIDIARIES
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
($000’s) Column A | | Column B | | Column C Additions | | Column D | | Column E | |
| |
| |
| |
| |
| |
Description | | Balance at beginning of year | | (1) Charged to costs and expenses | | (2) Charged to other accounts - describe | | Deductions - describe | | Balance at end of year | |
| |
| |
| |
| |
| |
| |
Allowance for doubtful accounts | | | | | | | | | | | | | | | | |
2004 | | $ | 2,500 | | $ | 544 | | $ | — | | $ | — | | $ | 3,044 | |
2003 | | $ | 1,600 | | $ | 900 | | $ | — | | $ | — | | $ | 2,500 | |
2002 | | $ | 1,200 | | $ | 400 | | $ | — | | $ | — | | $ | 1,600 | |
F-40
Schedule VI
PXRE GROUP LTD. AND SUBSIDIARIES
SUPPLEMENTARY INFORMATION CONCERNING
PROPERTY-CASUALTY INSURANCE OPERATIONS
| ($000’s) Column A | | Column B | | Column C | | Column D | | Column E | | Column F | | Column G | |
|
| |
| |
| |
| |
| |
| |
| |
| Affiliation with registrant | | Deferred policy acquisition costs | | Reserves for unpaid claims and claim adjustment expenses | | Discount, if any deducted in Column C | | Assumed unearned premiums | | Earned premiums | | Net investment Income | |
|
| |
| |
| |
| |
| |
| |
| |
2004 | Consolidated | | $ | 1,745 | | $ | 460,084 | | $ | — | | $ | 15,952 | | $ | 308,072 | | $ | 26,178 | |
2003 | Consolidated | | | 2,495 | | | 450,635 | | | — | | | 21,566 | | | 320,933 | | | 26,931 | |
2002 | Consolidated | | | 22,721 | | | 447,829 | | | — | | | 63,756 | | | 269,360 | | | 24,893 | |
| ($000’s) Column A | | Column H | | Column I | | Column J | | Column K | |
|
| |
| |
| |
| |
| |
| | | Claims and claim adjustment expenses incurred related to | | Amortization of deferred policy acquisition costs | | Paid claims and claim adjustment expenses | | Premiums written | |
| | |
| | | | |
| Affiliation with registrant | | (1) Current year | | (2) Prior years | | | | |
|
| |
| |
| |
| |
| |
| |
2004 | Consolidated | | $ | 214,316 | | $ | 12,031 | | $ | 34,326 | | $ | 132,121 | | $ | 309,787 | |
2003 | Consolidated | | | 112,917 | | | 44,681 | | | 42,326 | | | 93,015 | | | 278,411 | |
2002 | Consolidated | | | 101,456 | | | 23,905 | | | 49,868 | | | 99,877 | | | 294,483 | |
F-41
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
PXRE Group Ltd.:
We consent to the incorporation by reference in the registration statement (No. 333-85451) on Form S-4 of PXRE Group Ltd. of our report dated March 1, 2005, with respect to the consolidated balance sheets of PXRE Group Ltd., and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of income and comprehensive income, shareholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2004, and all related financial statement schedules, management's assessment of the effectiveness of internal control over financial reporting as of December 31, 2004 and the effectiveness of internal control over financial reporting as of December 31, 2004, which reports appear in the December 31, 2004 annual report on Form 10-K of PXRE Group Ltd.
As discussed in Note 2 to the consolidated financial statements, PXRE Group Ltd. adopted FASB Interpretation No. 46R “Consolidation of Variable Interest Entities,” during 2004.
/s/ KPMG LLP
New York, New York
March 1, 2005
F-42
EXHIBIT INDEX
Certain of the following exhibits, as indicated parenthetically, were previously filed as exhibits to registration statements filed by PXRE Group Ltd. or its predecessor companies under the Securities Act of 1933, as amended, or to reports filed by PXRE Group Ltd. or its predecessor companies under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are hereby incorporated by reference to such statements or reports. PXRE Group Ltd.’s Exchange Act file number is 1-15259. Prior to the reorganization that resulted in the formation of PXRE Group Ltd., PXRE Corporation’s Exchange Act file numbers were 1-12595 and 0-15428.
3.1 | Memorandum of Association of PXRE Group Ltd. (Exhibit 3.1 to PXRE Group Ltd.’s Form S-4 Registration Statement dated August 18, 1999). |
| |
3.2 | Bye-laws of PXRE Group Ltd. (Exhibit 3.2 to PXRE Group Ltd.’s Form S-4 Registration Statement dated August 18, 1999). |
| |
3.3 | Description of Stock of PXRE Group Ltd. (Appendix II to PXRE Group Ltd.’s Proxy Statement for the February 12, 2002 Special Meeting of Shareholders). |
| |
4.1 | Form of Specimen Common Share certificate, par value $1.00 per share, of PXRE Group Ltd. (Exhibit 4.1 to PXRE Group Ltd.’s Form S-4 Registration Statement dated August 18, 1999). |
| |
4.2 | Indenture, dated as of January 29, 1997, between PXRE Corporation and First Union National Bank, as Trustee, in respect of PXRE Corporation’s 8.85% Junior Subordinated Deferrable Interest Debentures due 2027 (Exhibit 4.3 to PXRE Corporation’s Annual Report on Form 10-K for the fiscal year ended December 31, 1996). |
| |
4.3 | First Supplemental Indenture, dated as of January 29, 1997, between PXRE Corporation and First Union National Bank, as Trustee, in respect of PXRE Corporation’s 8.85% Junior Subordinated Deferrable Interest Debentures due 2027 (Exhibit 4.4 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1996). |
| |
4.4 | Amended and Restated Declaration of Trust of PXRE Capital Trust I, dated as of January 29, 1997, among PXRE Corporation, as Sponsor, the Administrators thereof, First Union Bank of Delaware, as Delaware Trustee, First Union National Bank, as Institutional Trustee, and the holders from time to time of undivided interests in the assets of PXRE Capital Trust I (Exhibit 4.5 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1996). |
| |
4.5 | Capital Securities Guarantee Agreement, dated as of January 29, 1997, between PXRE Corporation and First Union National Bank, as Guarantee Trustee (Exhibit 4.6 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1996). |
4.6 | Common Securities Guarantee Agreement, dated as of January 29, 1997, executed by PXRE Corporation (Exhibit 4.7 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1996). |
| |
4.7 | Registration Rights Agreement dated as of January 29, 1997, among PXRE Corporation, PXRE Capital Trust I and Salomon Brothers Inc, as Representative of the Initial Purchasers (Exhibit 10.1 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1996). |
| |
4.8 | Investment Agreement, dated as of April 4, 2002 between PXRE Group Ltd. and certain Investors named therein (Appendix III to PXRE Group Ltd.’s Proxy Statement for the February 12, 2002 Special Meeting of Shareholders). |
| |
4.9 | Amended and Restated Declaration of Trust of PXRE Capital Statutory Trust II, dated as of May 15, 2003, among PXRE Group Ltd., as Sponsor, the Administrators thereof, U.S. Bank National Association, as Institutional Trustee, and the holders from time to time of undivided beneficial interests in the assets of PXRE Capital Statutory Trust II (Exhibit 10.1 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003). |
| |
4.10 | Indenture for Fixed/Floating Rate Junior Subordinated Deferrable Interest Debentures due 2033, dated as of May 15, 2003, among PXRE Group Ltd. as Issuer, and U.S. Bank National Association, as Trustee (Exhibit 10.2 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003). |
| |
4.11 | Guarantee Agreement, dated as of May 15, 2003, executed and delivered by PXRE Group Ltd., as Guarantor, and U.S. Bank National Association, as Trustee, for the benefit of the holders from time to time of the Capital Securities of PXRE Capital Statutory Trust II (Exhibit 10.3 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003). |
| |
4.12 | Amended and Restated Declaration of Trust of PXRE Capital Trust III, dated as of May 22, 2003, among PXRE Group Ltd., as Sponsor, the Administrators thereof, Wilmington Trust Company, as Delaware and Institutional Trustee, and the holders from time to time of undivided beneficial interests in the assets of PXRE Capital Trust III (Exhibit 10.6 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003). |
| |
4.13 | Indenture for Fixed Rate Junior Subordinated Debt Securities due 2033, dated as of May 22, 2003, among PXRE Group Ltd. as Issuer, and Wilmington Trust Company, as Trustee (Exhibit 10.7 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003). |
| |
4.14 | Guarantee Agreement, dated as of May 22, 2003, executed and delivered by PXRE Group Ltd., as Guarantor, and Wilmington Trust Company, as Trustee, for the benefit of the holders from time to time of the Capital Securities of PXRE Capital Trust III (Exhibit 10.8 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003). |
4.15 | Amended and Restated Declaration of Trust of PXRE Capital Statutory Trust V, dated as of October 29, 2003, among PXRE Group Ltd., as Sponsor, the Administrators thereof, U.S. Bank National Association, as Institutional Trustee, and the holders, from time to time, of undivided beneficial interests in the assets of PXRE Capital Statutory Trust V (Exhibit 4.23 to PXRE Group Ltd.’s Annual Report on Form 10-K for the year ended December 31, 2003). |
| |
4.16 | Indenture for Fixed/Floating Rate Junior Subordinated Deferrable Interest Debentures, Series D, due 2033, dated as of October 29, 2003, among PXRE Group Ltd. as Issuer, and U.S. Bank National Association, as Trustee (Exhibit 4.24 to PXRE Group Ltd.’s Annual Report on Form 10-K for the year ended December 31, 2003). |
| |
4.17 | Guarantee Agreement, dated as of October 29, 2003, executed and delivered by PXRE Group Ltd., as Guarantor, and U.S. Bank National Association, as Guarantee Trustee, for the benefit of the holders from time to time of the Capital Securities of PXRE Capital Statutory Trust V (Exhibit 4.25 to PXRE Group Ltd.’s Annual Report on Form 10-K for the year ended December 31, 2003). |
| |
4.18 | Amended and Restated Trust Agreement of PXRE Capital Trust VI, dated as of November 6, 2003, among PXRE Group Ltd., as Depositor, the Administrators thereof, JPMorgan Chase Bank, as Property Trustee, Chase Manhattan Bank USA, National Association, as Delaware Trustee, and the several Holders as defined therein (Exhibit 4.28 to PXRE Group Ltd.’s Annual Report on Form 10-K for the year ended December 31, 2003). |
| |
4.19 | Junior Subordinated Indenture, dated as of November 6, 2003, among PXRE Group Ltd. and JPMorgan Chase Bank, as Trustee (Exhibit 4.29 to PXRE Group Ltd.’s Annual Report on Form 10-K for the year ended December 31, 2003). |
| |
4.20 | Guarantee Agreement for PXRE Capital Trust VI, dated as of November 6, 2003, among PXRE Group Ltd., as Guarantor, and JPMorgan Chase Bank, as Guarantee Trustee (Exhibit 4.30 to PXRE Group Ltd.’s Annual Report on Form 10-K for the year ended December 31, 2003). |
| |
10.1 | Amended and Restated Facultative Obligatory Quota Share Retrocessional Agreement between PXRE Reinsurance Company and Select Reinsurance Ltd. and Variable Quota Share Retrocessional Agreement between PXRE Reinsurance Company and Select Reinsurance Ltd. (Exhibit 10.36 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1998); and endorsement regarding Select Reinsurance Ltd. participation for 2000 (Exhibit 10.3 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 1999); and endorsement, dated January 1, 2001, regarding Select Reinsurance Ltd. participation for 2001 (Exhibit 10.3 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2000); and endorsement dated March 21, 2002, regarding Select Reinsurance Ltd.’s participation for 2002 (Exhibit 10.3 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2001), Amendment to the Amended and Restated Facultative Obligatory Quota Share Retrocessional Agreement between Select Reinsurance Ltd. and PXRE Reinsurance Company dated November 20, 2002 (Exhibit 10.3 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2002) and letter to Select Reinsurance Ltd. from PXRE Reinsurance Company dated November 20, 2002 (Exhibit 10.3 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2002). |
10.2 | Endorsement to the Amended and Restated Facultative Obligatory Retrocessional Agreement, effective January 1, 2003, between PXRE Reinsurance Company, PXRE Reinsurance Ltd., and Select Reinsurance Ltd. (Exhibit 10.1 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003). |
| |
10.3 | Amendment to the Amended and Restated Facultative Obligatory Retrocessional Agreement, effective January 1, 2003, between Select Reinsurance Ltd., PXRE Reinsurance Company, and PXRE Reinsurance Ltd. (Exhibit 10.2 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003). |
| |
10.4 | Retrocession Contract, dated January 1, 2003, between PXRE Reinsurance Ltd. and Select Reinsurance Ltd. (Exhibit 10.3 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003). |
| |
10.5 | Amendment to the Retrocession Contract, effective October 1, 2003, between PXRE Reinsurance Ltd., PXRE Reinsurance Company and Select Reinsurance Ltd. (Exhibit 10.4 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003). |
| |
10.6 | Retrocessional Agreement, effective January 1, 2004 between Select Reinsurance Ltd. and PXRE Reinsurance Ltd. (Exhibit 10.1 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2004). |
| |
10.7 | Commutation Agreement, effective March 31, 2004, between Select Reinsurance Ltd., PXRE Reinsurance Company and PXRE Reinsurance Ltd. (Exhibit 10.2 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2004). |
| |
10.8 | Reinsurance Slip, effective April 1, 2004 between Select Reinsurance Ltd. and PXRE Reinsurance Ltd. (Exhibit 10.3 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2004). |
| |
10.9 | Deed of Trust for “The Patriot 2004 Trust”, dated June 30, 2004, among Select Reinsurance Ltd., Harrington Trust Limited, and PXRE Reinsurance Ltd. (Exhibit 10.3 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004). |
| |
10.10 | Commutation Agreement, effective September 30, 2004, between PXRE Reinsurance Company, PXRE Reinsurance Ltd., PXRE Group Ltd. and Select Reinsurance Ltd. (Exhibit 10.1 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004). |
10.11 | Commutation Agreement, effective January 1, 2005, between PXRE Reinsurance Ltd. and Select Reinsurance Ltd.* |
| |
10.12 | Facultative Obligatory Quota Share Retrocessional Agreement, effective October 1, 1999 between PXRE Reinsurance Company and PXRE Reinsurance Ltd. (Exhibit 10.25 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 1999). |
| |
10.13 | Aggregate Excess of Loss Agreement effective October 1, 1999 between PXRE Reinsurance Ltd. and PXRE Reinsurance Company (Exhibit 10.25 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 1999). |
| |
10.14 | Annex IV to Aggregate Excess of Loss Agreement, effective as of January 1, 2003 between PXRE Reinsurance Company and PXRE Reinsurance Ltd. (Exhibit 10.6 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2002). |
| |
10.15 | First Amendment to Facultative Obligatory Quota Share Retrocessional Agreement, dated as of December 1, 2000, between PXRE Reinsurance Ltd. and PXRE Reinsurance Company (Exhibit 10.22 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2000). |
| |
10.16 | Quota Share Endorsement to Facultative Obligatory Quota Share Retrocessional Agreement, effective as of January 1, 2003, between PXRE Reinsurance Ltd. and PXRE Reinsurance Company (Exhibit 10.6 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2002). |
| |
10.17 | Endorsement to Facultative Obligatory Quota Share Retrocessional Agreement, effective as of July 1, 2004, between PXRE Reinsurance Ltd. and PXRE Reinsurance Company.* |
| |
10.18 | Deed Poll Guarantee of PXRE Group Ltd. in respect of PXRE Reinsurance Ltd., dated as of September 1, 2002 (Exhibit 10.3a to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2002). |
| |
10.19 | Amended and Restated Agreement Concerning Filing of Consolidated Federal Income Tax Returns, dated as of August 23, 1993, between PXRE Corporation and PXRE Reinsurance Company (Exhibit 10.8 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1993); Addendum No. 2, dated November 10, 1994, to the PXRE Corporation Amended and Restated Agreement Concerning Filing of Consolidated Federal Income Tax Returns (Exhibit 10.22 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1994); Addendum No. 3, dated as of December 11, 1996 to the PXRE Corporation Amended and Restated Agreement Concerning Filing of Consolidated Federal Income Tax Returns (Exhibit 10.22 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1996); and Addendum No. 4 to the PXRE Group Amended and Restated Agreement Concerning Filing of Consolidated Federal Income Tax Return between PXRE Corporation and Transnational Insurance Company (Exhibit 10.9 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2000). |
10.20 | Investment Advisory Services Agreement between PXRE Reinsurance Ltd. and Mariner Investment Group, Inc., dated October 1, 1999 (Exhibit 10.10 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 1999). |
| |
10.21 | Investment Advisory Services Agreement, dated March 14, 2000, between PXRE Corporation and Mariner Investment Group, Inc., (Exhibit 10.34 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 1999). |
| |
10.22 | NEAM Investment Management Agreement, dated April 8, 2002, between General Re-New England Asset Management, Inc. and PXRE Reinsurance Company; Investment Management Agreement, dated April 8, 2002, between General Re-New England Asset Management, Inc. and PXRE Group Ltd.; Investment Management Agreement, dated April 8, 2002 between General Re-New England Asset Management, Inc. and PXRE Reinsurance Ltd. (Exhibit 10.1 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2002). |
| |
10.23 | PXRE Group Ltd. Employee Stock Purchase Plan as amended and restated February 13, 2002 (Appendix B to PXRE Group Ltd.’s Proxy Statement for the 2002 Annual General Meeting of Shareholders). (M) |
| |
10.24 | Amended and Restated Executive Severance Plan for Certain Executives of PXRE Group Ltd. dated May 5, 2004.* |
| |
10.25 | 1988 Stock Option Plan as amended (Exhibit A to the first Prospectus forming part of PXRE Corporation’s Form S-8 and S-3 Registration Statement dated June 21, 1990). (M) |
| |
10.26 | Restated Employee Annual Incentive Bonus Plan, as amended and restated (Appendix A to PXRE Group Ltd.’s Proxy Statement for the 2000 Annual General Meeting of Shareholders). (M) |
| |
10.27 | 1992 Officer Incentive Plan as amended (Appendix B to PXRE Group Ltd.’s Proxy Statement for the 2000 Annual General Meeting of Shareholders). (M) |
| |
10.28 | 2002 Officer Incentive Plan as amended (Appendix A to PXRE Group Ltd.’s Proxy Statement for the 2002 Annual Meeting of Shareholders). (M) |
| |
10.29 | Director Stock Plan (Appendix D to PXRE Group Ltd.’s Proxy Statement for the 2000 Annual General Meeting of Shareholders). (M) |
|
(M) Indicates a management contract or compensation plan or arrangement in which the directors and/or executive or PXRE participate. |
* Filed Herewith. |
10.30 | Director Equity and Deferred Compensation Plan (Appendix E to PXRE Group Ltd.’s Proxy Statement for the 2000 Annual General Meeting of Shareholders). (M) |
| |
10.31 | Non-Employee Director Deferred Stock Plan (Exhibit 10.17 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2000). (M) |
| |
10.32 | 2004 Incentive Bonus Compensation Plan (Appendix B to PXRE Group Ltd.’s Proxy Statement for the 2004 Annual Meeting of Shareholders). (M) |
| |
10.33 | Lease, dated May 9, 1994, between Thornall Associates, L.P. and PXRE Corporation (Exhibit 10.24 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1994); Lease, dated November 1, 1999, between Thornall Associates, L.P. and PXRE Corporation (Exhibit 10.26 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 1999); and Sublease, dated July 1, 2000, between I-many, Inc. and PXRE Corporation (Exhibit 10.23 to the Annual Report on Form 10-K of PXRE Group Ltd. for the fiscal year ended December 31, 2000). |
| |
10.34 | Lease, dated February 23, 2005, between Barr’s Bay Properties Limited and PXRE Reinsurance Ltd.* |
| |
10.35 | Lloyd’s Deposit Trust Deed (Third Party Deposit) dated November 29, 1996 between PXRE Limited and PXRE Reinsurance Company (Exhibit 10.32 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1997). |
| |
10.36 | Lloyd’s Security and Trust Deed (Letter of Credit and Bank Guarantee) dated November 29, 1997, between PXRE Limited and Lloyd’s of London (Exhibit 10.34 to the Annual Report on Form 10-K of PXRE Corporation for the fiscal year ended December 31, 1997). |
| |
10.37 | Consulting Services Agreement, dated as of May 28, 2003 by and among PXRE Group Ltd., and Gerald L. Radke (Exhibit 10.1 to PXRE Group Ltd.’s Current Report on Form 8-K dated June 4, 2003). (M) |
| |
10.38 | Employment Agreement, dated as of June 30, 2003, among PXRE Group Ltd. and Jeffrey L. Radke. (Exhibit 10.13 to PXRE Group Ltd.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003). (M) |
| |
10.39 | Employment Agreement, dated August 27, 2004, by and between PXRE Reinsurance Ltd. and Guy D. Hengesbaugh, President & Chief Operating Officer of PXRE Reinsurance Ltd. (Exhibit 99.1 to PXRE Group Ltd.’s Current Report on Form 8-K dated August 31, 2004). (M) |
|
* Filed Herewith. |
(M) Indicates a management contract or compensation plan or arrangement in which the directors and/or executive or PXRE participate. |
10.40 | Employment Agreement, dated August 27, 2004, by and between PXRE Group Ltd. and John M. Modin, Executive Vice President & Chief Financial Officer of PXRE Group Ltd. (Exhibit 99.2 to PXRE Group Ltd.’s Current Report on Form 8-K dated August 31, 2004). (M) |
| |
10.41 | Employment Agreement, dated August 27, 2004, by and between PXRE Reinsurance Company and Bruce J. Byrnes, General Counsel & Secretary of PXRE Reinsurance Company (Exhibit 99.3 to PXRE Group Ltd.’s Current Report on Form 8-K dated August 31, 2004).(M) |
| |
10.42 | Employment Agreement, dated September 1, 2004, by and between PXRE Reinsurance Ltd. and John T. Daly, Executive Vice President of PXRE Reinsurance Ltd. (Exhibit 99.1 to PXRE Group Ltd.’s Current Report on Form 8-K dated September 2, 2004). (M) |
| |
10.43 | Letter of Credit Facility Agreement, dated June 25, 2004, between PXRE Reinsurance Ltd., as Borrower, and Barclays Bank PLC, as Issuer (Exhibit 10.1 to PXRE Group Ltd.’s Current Report on Form 8-K filed June 25, 2004). |
| |
10.44 | Security Agreement, dated June 25, 2004, between Barclays Bank PLC, as Secured Party, and PXRE Reinsurance Ltd., as Borrower (Exhibit 10.2 to PXRE Group Ltd.’s Current Report on Form 8-K filed June 25, 2004). |
| |
10.45 | Global Amendment Agreement to the Letter of Credit Facility Agreement, dated January 28, 2005, between PXRE Reinsurance Ltd., as Borrower, and Barclays Bank PLC, as Issuer (Exhibit 99.1 to PXRE Group Ltd.’s Current Report on Form 8-K filed January 28, 2005). |
| |
11 | Statement setting forth computation of earnings per share. The information required by this Exhibit is presented in the financial statements and the notes thereto included in this Form 10-K. |
| |
12 | Statement setting forth computation of ratios. Attached hereto as Exhibit 12. |
| |
21 | List of Subsidiaries. Attached hereto as Exhibit 21. |
| |
23 | Consents of Experts and Counsel. The consent of KPMG LLP, independent accountants to PXRE, are included as part of Item 14(a)(2) of this Form 10-K. |
| |
24 | Power of Attorney. Copies of the powers of attorney executed by each of Gerald L. Radke, F. Sedgwick Browne, Susan F. Cabrera, Bradley E. Cooper, Robert W. Fiondella, Franklin D. Haftl, Craig A. Huff, Mural R. Josephson, Wendy Luscombe, Philip R. McLoughlin, and Robert M. Stavis are attached hereto as Exhibit 24. |
|
(M) Indicates a management contract or compensation plan or arrangement in which the directors and/or executive or PXRE participate. |
31.1 | Certification by the Chief Executive Officer Relating to a Periodic Report Containing Financial Statements pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
31.2 | Certification by the Chief Financial Officer Relating to a Periodic Report Containing Financial Statements Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
32.1 | Certification of Periodic Report Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |